<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/528E44D9-BB41-4FB4-B870-A420A440EDBF"><gtr:id>528E44D9-BB41-4FB4-B870-A420A440EDBF</gtr:id><gtr:name>Sakhalin State University</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7A468659-CE74-4F8F-91FB-F14404250B19"><gtr:id>7A468659-CE74-4F8F-91FB-F14404250B19</gtr:id><gtr:name>University of Athens</gtr:name><gtr:address><gtr:line1>Panepistimiopolis</gtr:line1><gtr:line4>Athens</gtr:line4><gtr:line5>157 71</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Greece</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9A42FA32-87CB-461C-8DB7-9064771DD1D6"><gtr:id>9A42FA32-87CB-461C-8DB7-9064771DD1D6</gtr:id><gtr:name>Ataxia UK</gtr:name><gtr:address><gtr:line1>Lincoln House</gtr:line1><gtr:line2>Kennington Park</gtr:line2><gtr:line3>1-3 Brixton Road</gtr:line3><gtr:postCode>SW9 6DE</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2493173D-13F6-44C1-B923-B6C6ABF357C0"><gtr:id>2493173D-13F6-44C1-B923-B6C6ABF357C0</gtr:id><gtr:name>University of Tehran</gtr:name><gtr:address><gtr:line1>16 Azar Street</gtr:line1><gtr:line2>Enghelab Ave</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4A179E2C-FB5E-4836-AA80-6301F4DD5AB6"><gtr:id>4A179E2C-FB5E-4836-AA80-6301F4DD5AB6</gtr:id><gtr:name>University of Sydney</gtr:name><gtr:address><gtr:line1>University of Sydney</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/6F0E9705-31FF-4C65-9BEC-AAC5156FB56D"><gtr:id>6F0E9705-31FF-4C65-9BEC-AAC5156FB56D</gtr:id><gtr:name>British Medical Association (BMA)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/90D89AF1-B099-4AD3-AF5B-00C648062DC2"><gtr:id>90D89AF1-B099-4AD3-AF5B-00C648062DC2</gtr:id><gtr:name>National Organization for Rare Disorders (NORD)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/91C308E2-1EBA-4CC1-8183-0371468DE15E"><gtr:id>91C308E2-1EBA-4CC1-8183-0371468DE15E</gtr:id><gtr:name>Wayne State University</gtr:name><gtr:address><gtr:line1>Detroit</gtr:line1><gtr:line2>Michigan</gtr:line2><gtr:line3>MI 48202</gtr:line3><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D7A9497E-C70A-4959-A29E-A16EB801E857"><gtr:id>D7A9497E-C70A-4959-A29E-A16EB801E857</gtr:id><gtr:name>Sanford Heart Hospital</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/0407B94D-DABF-4B46-B5F0-2CBDC1C63C67"><gtr:id>0407B94D-DABF-4B46-B5F0-2CBDC1C63C67</gtr:id><gtr:name>national Institute on Aging</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/47977EA7-B9F8-4D02-9BD2-FD4D34F2644D"><gtr:id>47977EA7-B9F8-4D02-9BD2-FD4D34F2644D</gtr:id><gtr:name>Genomics England</gtr:name><gtr:address><gtr:line1>Queen Mary University of London</gtr:line1><gtr:line2>Dawson Hall</gtr:line2><gtr:line3>Charterhouse Square</gtr:line3><gtr:postCode>EC1M 6BQ</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3B1E5961-8677-4A32-B15C-12FB968FA163"><gtr:id>3B1E5961-8677-4A32-B15C-12FB968FA163</gtr:id><gtr:name>University of Pennsylvania</gtr:name><gtr:address><gtr:line1>3451 Walnut Street,</gtr:line1><gtr:line2>Suite P-221</gtr:line2><gtr:line3>Franklin Building</gtr:line3><gtr:line4>Philadelphia</gtr:line4><gtr:postCode>PA 19104</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DAEB2B76-3CE2-4F67-BE52-859227BD2B8F"><gtr:id>DAEB2B76-3CE2-4F67-BE52-859227BD2B8F</gtr:id><gtr:name>Great Ormond Street Hospital (GOSH)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A8B346A4-B170-4B93-86F0-EAFAC0A94BCC"><gtr:id>A8B346A4-B170-4B93-86F0-EAFAC0A94BCC</gtr:id><gtr:name>University of Thessaly</gtr:name><gtr:address><gtr:line1>Argonafton &amp; Filellinon</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F7BE6197-72FC-41EB-99F4-738055C2C57B"><gtr:id>F7BE6197-72FC-41EB-99F4-738055C2C57B</gtr:id><gtr:name>Sarah Matheson Trust for MSA</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3CCE6BCD-27BA-45CA-B5B0-5890F9F9B4F9"><gtr:id>3CCE6BCD-27BA-45CA-B5B0-5890F9F9B4F9</gtr:id><gtr:name>Partnership for Advanced Computing in Europe (PRACE)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/EF6B1E83-9BAD-4ED0-B2A0-5E1A69687339"><gtr:id>EF6B1E83-9BAD-4ED0-B2A0-5E1A69687339</gtr:id><gtr:name>European Commission</gtr:name><gtr:address><gtr:line1>Wetstraat 200 / Rue de la Loi 200</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Belgium</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/89D5574C-AAF7-4D96-832C-C2BA623123CE"><gtr:id>89D5574C-AAF7-4D96-832C-C2BA623123CE</gtr:id><gtr:name>Eberhard Karls University Tuebingen</gtr:name><gtr:address><gtr:line1>Wilhelmstra?e 7</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>Institute of Neurology</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/528E44D9-BB41-4FB4-B870-A420A440EDBF"><gtr:id>528E44D9-BB41-4FB4-B870-A420A440EDBF</gtr:id><gtr:name>Sakhalin State University</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7A468659-CE74-4F8F-91FB-F14404250B19"><gtr:id>7A468659-CE74-4F8F-91FB-F14404250B19</gtr:id><gtr:name>University of Athens</gtr:name><gtr:address><gtr:line1>Panepistimiopolis</gtr:line1><gtr:line4>Athens</gtr:line4><gtr:line5>157 71</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Greece</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9A42FA32-87CB-461C-8DB7-9064771DD1D6"><gtr:id>9A42FA32-87CB-461C-8DB7-9064771DD1D6</gtr:id><gtr:name>Ataxia UK</gtr:name><gtr:address><gtr:line1>Lincoln House</gtr:line1><gtr:line2>Kennington Park</gtr:line2><gtr:line3>1-3 Brixton Road</gtr:line3><gtr:postCode>SW9 6DE</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2493173D-13F6-44C1-B923-B6C6ABF357C0"><gtr:id>2493173D-13F6-44C1-B923-B6C6ABF357C0</gtr:id><gtr:name>University of Tehran</gtr:name><gtr:address><gtr:line1>16 Azar Street</gtr:line1><gtr:line2>Enghelab Ave</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4A179E2C-FB5E-4836-AA80-6301F4DD5AB6"><gtr:id>4A179E2C-FB5E-4836-AA80-6301F4DD5AB6</gtr:id><gtr:name>University of Sydney</gtr:name><gtr:address><gtr:line1>University of Sydney</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6F0E9705-31FF-4C65-9BEC-AAC5156FB56D"><gtr:id>6F0E9705-31FF-4C65-9BEC-AAC5156FB56D</gtr:id><gtr:name>British Medical Association (BMA)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/90D89AF1-B099-4AD3-AF5B-00C648062DC2"><gtr:id>90D89AF1-B099-4AD3-AF5B-00C648062DC2</gtr:id><gtr:name>National Organization for Rare Disorders (NORD)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/91C308E2-1EBA-4CC1-8183-0371468DE15E"><gtr:id>91C308E2-1EBA-4CC1-8183-0371468DE15E</gtr:id><gtr:name>Wayne State University</gtr:name><gtr:address><gtr:line1>Detroit</gtr:line1><gtr:line2>Michigan</gtr:line2><gtr:line3>MI 48202</gtr:line3><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D7A9497E-C70A-4959-A29E-A16EB801E857"><gtr:id>D7A9497E-C70A-4959-A29E-A16EB801E857</gtr:id><gtr:name>Sanford Heart Hospital</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0407B94D-DABF-4B46-B5F0-2CBDC1C63C67"><gtr:id>0407B94D-DABF-4B46-B5F0-2CBDC1C63C67</gtr:id><gtr:name>national Institute on Aging</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/47977EA7-B9F8-4D02-9BD2-FD4D34F2644D"><gtr:id>47977EA7-B9F8-4D02-9BD2-FD4D34F2644D</gtr:id><gtr:name>Genomics England</gtr:name><gtr:address><gtr:line1>Queen Mary University of London</gtr:line1><gtr:line2>Dawson Hall</gtr:line2><gtr:line3>Charterhouse Square</gtr:line3><gtr:postCode>EC1M 6BQ</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3B1E5961-8677-4A32-B15C-12FB968FA163"><gtr:id>3B1E5961-8677-4A32-B15C-12FB968FA163</gtr:id><gtr:name>University of Pennsylvania</gtr:name><gtr:address><gtr:line1>3451 Walnut Street,</gtr:line1><gtr:line2>Suite P-221</gtr:line2><gtr:line3>Franklin Building</gtr:line3><gtr:line4>Philadelphia</gtr:line4><gtr:postCode>PA 19104</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DAEB2B76-3CE2-4F67-BE52-859227BD2B8F"><gtr:id>DAEB2B76-3CE2-4F67-BE52-859227BD2B8F</gtr:id><gtr:name>Great Ormond Street Hospital (GOSH)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A8B346A4-B170-4B93-86F0-EAFAC0A94BCC"><gtr:id>A8B346A4-B170-4B93-86F0-EAFAC0A94BCC</gtr:id><gtr:name>University of Thessaly</gtr:name><gtr:address><gtr:line1>Argonafton &amp; Filellinon</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F7BE6197-72FC-41EB-99F4-738055C2C57B"><gtr:id>F7BE6197-72FC-41EB-99F4-738055C2C57B</gtr:id><gtr:name>Sarah Matheson Trust for MSA</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3CCE6BCD-27BA-45CA-B5B0-5890F9F9B4F9"><gtr:id>3CCE6BCD-27BA-45CA-B5B0-5890F9F9B4F9</gtr:id><gtr:name>Partnership for Advanced Computing in Europe (PRACE)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/EF6B1E83-9BAD-4ED0-B2A0-5E1A69687339"><gtr:id>EF6B1E83-9BAD-4ED0-B2A0-5E1A69687339</gtr:id><gtr:name>European Commission</gtr:name><gtr:address><gtr:line1>Wetstraat 200 / Rue de la Loi 200</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Belgium</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/89D5574C-AAF7-4D96-832C-C2BA623123CE"><gtr:id>89D5574C-AAF7-4D96-832C-C2BA623123CE</gtr:id><gtr:name>Eberhard Karls University Tuebingen</gtr:name><gtr:address><gtr:line1>Wilhelmstra?e 7</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/2761A603-5EF4-4006-8C7C-FBD7F3D90FC5"><gtr:id>2761A603-5EF4-4006-8C7C-FBD7F3D90FC5</gtr:id><gtr:firstName>John</gtr:firstName><gtr:surname>Hardy</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/002FC006-2518-458A-AB1F-FF4586FFE8D7"><gtr:id>002FC006-2518-458A-AB1F-FF4586FFE8D7</gtr:id><gtr:firstName>Michael</gtr:firstName><gtr:surname>Hanna</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/7DB72BBB-9361-4E06-9660-D86B9C640511"><gtr:id>7DB72BBB-9361-4E06-9660-D86B9C640511</gtr:id><gtr:firstName>Coro</gtr:firstName><gtr:surname>Paisan-Ruiz</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/108C8639-97B3-4979-8864-2921F57B9B5D"><gtr:id>108C8639-97B3-4979-8864-2921F57B9B5D</gtr:id><gtr:firstName>Joshua</gtr:firstName><gtr:surname>Hersheson</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/C7FEA0B7-1227-4A7E-95CF-50D321AB8DCB"><gtr:id>C7FEA0B7-1227-4A7E-95CF-50D321AB8DCB</gtr:id><gtr:firstName>Henry</gtr:firstName><gtr:surname>Houlden</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/74F3B285-F862-4051-A76A-9A4272BB626C"><gtr:id>74F3B285-F862-4051-A76A-9A4272BB626C</gtr:id><gtr:firstName>Mary</gtr:firstName><gtr:otherNames>Margaret</gtr:otherNames><gtr:surname>Reilly</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G1001253"><gtr:id>5A97E264-A7E5-459F-A08D-C0D180FEC3FB</gtr:id><gtr:title>Genetic Dissection of Neuromuscular Disorders</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G1001253</gtr:grantReference><gtr:abstractText>Peripheral neuropathy is common, affecting approximately 2.5% of the UK population. When inherited in a family the condition is usually called Charcot-Marie-Tooth disease (CMT) and is one of the commonest inherited neurological disorders affecting 1 in 2500 people.

CMT usually starts in childhood or teenage years with progressive distal limb weakness, muscle wasting and glove and stocking sensory loss. Walking problems and foot deformities are common requiring ankle or leg supports, sticks and later wheelchair use. Many patients develop complications such as pain, degeneration of the joints, scoliosis and limb ulcers. There is no effective treatment available. CMT can essentially be divided into type 1 (CMT1) that affects the nerve myelin sheath or type 2 (CMT2) that affects the nerve axon. The motor form of CMT is called distal hereditary motor neuropathy (HMN) and the sensory form hereditary sensory and autonomic neuropathy (HSAN). There a number of genes that when defective, can cause CMT. The majority have been identified in CMT1, few genes in only a small proportion of cases have been found in the other types of CMT. Around 40% of CMT patients remain genetically unknown.

Next generation sequencing technology has transformed our ability to identify disease genes. Mutations in the protein encoding exons of genes account for most of human genetic diseases. We can now use revolutionary enrichment methods to select all the exons to sequence in an individual (exome) using this technology. In our laboratory we have established an effective exome sequencing pipeline which is perfectly suited to CMT gene identification, in small families or groups of patients with very similar phenotypes. 

We propose an unprecedented gene discovery effort to identify and characterise a large proportion of the unknown CMT genes. We will focus on exome sequencing 100 CMT families, divided between CMT1, CMT2, distal HMN and HSAN. We expect to identify a number of disease genes, prove these defects and examine our entire series of CMT patients. Many genetic defects will require studies on other patient material such as fresh blood to prove the mutation mechanism. To further analyse the function of the CMT genes identified we have established a number of fruitful collaborations. We expect genes to cluster into pathways that are important for peripheral nerve homeostasis and when defective lead to nerve degeneration. Through the identification of these processes we hope to reveal treatment targets that will be promising candidates for therapeutic drug trials.</gtr:abstractText><gtr:technicalSummary>Peripheral neuropathy is common, affecting approximately 2.5% of the UK population. Inherited neuropathy is usually called Charcot-Marie-Tooth disease (CMT) and is one of the commonest inherited neurological disorders affecting 1 in 2500 people.

CMT usually starts in childhood or teenage years with progressive distal limb weakness, muscle wasting and glove and stocking sensory loss. Walking problems and foot deformities are common requiring orthoses, sticks and later wheelchair use. CMT is genetically heterogeneous with over 30 genes identified that have revealing important biological insights into the pathophysiology of the peripheral nervous system. The majority of genes have been identified in the demyelinating form of CMT (type 1), few genes in only a small proportion of cases have been found in the other types of CMT. After excluding the known genes, around 40% of CMT patients remain genetically undefined.

Here we propose an unprecedented gene discovery effort to identify and characterise a large proportion of the unknown CMT genes. In the past we have been limited by the sequencing technology and the size of families, however, we can now perform whole exome sequencing of all protein encoding regions (exome) and flanking intron boundaries from enriched patient DNA samples. In our laboratory we have established next generation sequencing developing an effective exome sequencing pipeline that has so far, identified one novel disease gene. This method is perfectly suited to CMT gene identification, in small families or groups of patients with very similar phenotypes. 

Whole exome sequencing will be performed in 100 CMT families. Half the families will be dominant and half recessive, divided between CMT1, CMT2, distal HMN and HSAN. In dominant families two individuals will be sequenced and in the recessives one. After thorough filtering and bioinformatic analysis we expect to identify a number of disease genes, prove these defects in families and then examine our extensive CMT database of cases to assess frequency, mutation spectrum and phenotype correlations. Many genetic defects will require protein and/or RNA studies from patient material to prove the mutation mechanism. True functional analysis is beyond the scope of this proposal but we have established a number of fruitful collaborations that have allowed the successful investigation of CMT genes. We expect these genes to cluster into pathways that are important for peripheral nerve homeostasis and when defective lead to nerve degeneration. Through the identification of these processes the hope must be that treatment targets will become apparent.</gtr:technicalSummary><gtr:fund><gtr:end>2015-02-06</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2011-09-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>519262</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>European Commission</gtr:collaboratingOrganisation><gtr:country>European Union (EU)</gtr:country><gtr:department>Seventh Framework Programme (FP7)</gtr:department><gtr:description>Neuromics FP7 collaboration</gtr:description><gtr:id>9185AA26-FA86-4FD3-97CE-5DE9230C2002</gtr:id><gtr:impact>Publications, collaboration and preparation for other rare disease grants</gtr:impact><gtr:outcomeId>56dda6ff4d69f2.22859113-1</gtr:outcomeId><gtr:partnerContribution>Shared results and materials - genome/exome sequencing, functional data and patient materials</gtr:partnerContribution><gtr:piContribution>Neuromics FP7 collaboration where we received funding for a post-doc (to prof hanna) and also funding for sequencing.
There was significant collaboration and added value from this collaboration with shared results and materials</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Sydney</gtr:collaboratingOrganisation><gtr:country>Australia, Commonwealth of</gtr:country><gtr:department>Brain and Mind Research Institute</gtr:department><gtr:description>Childhood Motor Neuron Disease consortium</gtr:description><gtr:id>A0E06B55-521D-4653-9EAA-1BBF9BF32797</gtr:id><gtr:impact>A number of DNA samples and fibroblasts collected</gtr:impact><gtr:outcomeId>Kh4BVG8DYez-2</gtr:outcomeId><gtr:partnerContribution>Collaborators have provided clinical details, cells, DNA for exome sequencing and gene identification</gtr:partnerContribution><gtr:piContribution>Collaborative group that have collected clinical details, cells, DNA and treatment responses on Childhood Motor Neuron Disease</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institute on Aging</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Laboratory of Neurogenetics, NIA and NIH, USA</gtr:description><gtr:id>3F2E24E1-E8D0-4075-B664-037EBED7B075</gtr:id><gtr:impact>Publications, assistance with grants</gtr:impact><gtr:outcomeId>Xs8yYa5ZzDo-1</gtr:outcomeId><gtr:partnerContribution>Sharing of data, cases and techniquesData and publications</gtr:partnerContribution><gtr:piContribution>Data, cases, publications</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Tehran</gtr:collaboratingOrganisation><gtr:country>Iran, Islamic Republic of</gtr:country><gtr:description>University of Tehran</gtr:description><gtr:id>CDF04A65-E852-4987-8436-F27F555D918C</gtr:id><gtr:impact>Prof Elahe has provided many inportant families for our research and we currently share a PhD student</gtr:impact><gtr:outcomeId>j7X5YhDsm95-1</gtr:outcomeId><gtr:partnerContribution>Prof Elahe has provided many inportant families for our research and we currently share a PhD student</gtr:partnerContribution><gtr:piContribution>Prof Elahe has provided many inportant families for our research and we currently share a PhD student</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Athens</gtr:collaboratingOrganisation><gtr:country>Greece, Hellenic Republic</gtr:country><gtr:department>Neurology Athens</gtr:department><gtr:description>Athens collaboration on ataxia and neuropathy</gtr:description><gtr:id>1D7DD7FB-CDB2-4C88-B369-D0D16F065D4E</gtr:id><gtr:impact>Large Greek study on ataxia and neuropathy in Greece</gtr:impact><gtr:outcomeId>GvFsmF4nAKm-1</gtr:outcomeId><gtr:piContribution>Large Greek study on ataxia and neuropathy in Greece</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Sarah Matheson Trust for MSA</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>MSA Trust</gtr:description><gtr:id>9BD432D8-614A-4F78-ABF2-B8F62EA1A8A7</gtr:id><gtr:impact>Publications, data, tours of the lab, newsletter information</gtr:impact><gtr:outcomeId>eodK9WGCHrW-1</gtr:outcomeId><gtr:partnerContribution>Patients, we write a research update in the newletter, many patients have given blood and donated their brain as a result of the research</gtr:partnerContribution><gtr:piContribution>Data, tours of the lab, newsletter information</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Sakhalin State University</gtr:collaboratingOrganisation><gtr:country>Russian Federation</gtr:country><gtr:description>Sakhalin Universitycollaboration</gtr:description><gtr:id>8E273DE7-3D5F-478E-A3DF-FF6CB6D5A487</gtr:id><gtr:impact>ongoing</gtr:impact><gtr:outcomeId>GiKwEB27NTk-1</gtr:outcomeId><gtr:piContribution>Collaboration on patients with Neuropathy in Russia</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institute on Aging</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Laboratory of Neurogenetics, NIA and NIH, USA</gtr:description><gtr:id>346482F6-C33F-4F3F-8CE2-B0BB85B4738F</gtr:id><gtr:impact>Publications, assistance with grants</gtr:impact><gtr:outcomeId>Xs8yYa5ZzDo-2</gtr:outcomeId><gtr:partnerContribution>Sharing of data, cases and techniquesData and publications</gtr:partnerContribution><gtr:piContribution>Data, cases, publications</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Athens</gtr:collaboratingOrganisation><gtr:country>Greece, Hellenic Republic</gtr:country><gtr:department>Neurology Athens</gtr:department><gtr:description>Greek Collaboration on neurogenetics - Athens, Thessaloniki and Larisa</gtr:description><gtr:id>E0E93C85-4D34-4616-A887-BCE88ABD87BF</gtr:id><gtr:impact>Sharing of families and data</gtr:impact><gtr:outcomeId>5463d47cdc4257.17558439-1</gtr:outcomeId><gtr:partnerContribution>Greek Collaboration on neurogenetics - Athens, Thessaloniki and Larisa
Sharing of DNA and clinical details on series and families</gtr:partnerContribution><gtr:piContribution>Greek Collaboration on neurogenetics - Athens, Thessaloniki and Larisa
Sharing of DNA and clinical details on series and families</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Great Ormond Street Hospital (GOSH)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Neurology</gtr:department><gtr:description>Childhood Motor Neuron Disease consortium</gtr:description><gtr:id>9C011B3C-FA8B-4466-9F30-F49BF0A51CC2</gtr:id><gtr:impact>A number of DNA samples and fibroblasts collected</gtr:impact><gtr:outcomeId>Kh4BVG8DYez-3</gtr:outcomeId><gtr:partnerContribution>Collaborators have provided clinical details, cells, DNA for exome sequencing and gene identification</gtr:partnerContribution><gtr:piContribution>Collaborative group that have collected clinical details, cells, DNA and treatment responses on Childhood Motor Neuron Disease</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Sarah Matheson Trust for MSA</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Sarah Matheson Trust for MSA</gtr:description><gtr:id>3E614160-8253-49C3-9802-6A44CF72DE8B</gtr:id><gtr:impact>Publications, Brought patients and encouraged brain donation of MSA patients for our research</gtr:impact><gtr:outcomeId>921118C1E24-1</gtr:outcomeId><gtr:partnerContribution>Brought patients and encouraged brain donation of MSA patients for our research</gtr:partnerContribution><gtr:piContribution>Brought patients and encouraged brain donation of MSA patients for our research</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC UK Brain Banks Network</gtr:department><gtr:description>European Brain Bank Network</gtr:description><gtr:id>FF89FA75-A1D4-40FA-9E4C-96D0C1BEDCD2</gtr:id><gtr:impact>Brain tissue for our research</gtr:impact><gtr:outcomeId>iWsvpuzpkvw-1</gtr:outcomeId><gtr:partnerContribution>Brain tissue for research</gtr:partnerContribution><gtr:piContribution>Brain tissue for our research</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Pennsylvania</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Neurology</gtr:department><gtr:description>Childhood Motor Neuron Disease consortium</gtr:description><gtr:id>A0946C6F-D512-43BD-A154-FC2694F6CF9C</gtr:id><gtr:impact>A number of DNA samples and fibroblasts collected</gtr:impact><gtr:outcomeId>Kh4BVG8DYez-1</gtr:outcomeId><gtr:partnerContribution>Collaborators have provided clinical details, cells, DNA for exome sequencing and gene identification</gtr:partnerContribution><gtr:piContribution>Collaborative group that have collected clinical details, cells, DNA and treatment responses on Childhood Motor Neuron Disease</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Pennsylvania</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>School of Veterinary Medicine (UPenn)</gtr:department><gtr:description>PENN collaboration on Dog ataxia and neuropathy</gtr:description><gtr:id>2FD62DFB-1CD6-4221-9599-7151B783A0DE</gtr:id><gtr:impact>Joint grant submitted to NIH</gtr:impact><gtr:outcomeId>FnkjAQW7K1f-1</gtr:outcomeId><gtr:partnerContribution>Provided tissue and clinical details</gtr:partnerContribution><gtr:piContribution>PENN collaboration on Dog ataxia and neuropathy.

We are working on the genetics of neuropathy and ataxia in dog models of human disease</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Ataxia UK</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Ataxia UK</gtr:description><gtr:id>E158A6B9-9615-4716-8FCB-742751F8916C</gtr:id><gtr:impact>Publications, made UK patients with Ataxia more aware</gtr:impact><gtr:outcomeId>A7FFBA7590F-1</gtr:outcomeId><gtr:partnerContribution>Made members aware of our work, identified patients and families</gtr:partnerContribution><gtr:piContribution>Information and genetic analysis of patients</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Eberhard Karls University of Tubingen</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Neuromics</gtr:department><gtr:description>Neuromics neurogenetics collaboration</gtr:description><gtr:id>A75002D5-FEF7-46E8-B48F-7621842D710B</gtr:id><gtr:impact>Recently started</gtr:impact><gtr:outcomeId>ncvkmb8CSLy-1</gtr:outcomeId><gtr:partnerContribution>Groups working on several areas of genetics</gtr:partnerContribution><gtr:piContribution>We are the channelopathy and ataxia part of the collaboration. Our role is exome sequencing, genetics and expression</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Genomics England</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Genomics England Genome Sequencing (100,000 genomes) and Neurology GeCIP (HH is co-lead)</gtr:description><gtr:id>D07A8632-F466-4887-918D-304AACF926DF</gtr:id><gtr:impact>Genomics England Genome Sequencing (100,000 genomes) and Neurology GeCIP (HH is co-lead)</gtr:impact><gtr:outcomeId>56ddaab95929e7.94396092-1</gtr:outcomeId><gtr:partnerContribution>Genomics England Genome Sequencing (100,000 genomes) and Neurology GeCIP (HH is co-lead)</gtr:partnerContribution><gtr:piContribution>Genomics England Genome Sequencing (100,000 genomes) and Neurology GeCIP (HH is co-lead)</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Wayne State University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Wayne State University</gtr:description><gtr:id>BF88606E-C433-43F3-A0FE-F51A6B40A366</gtr:id><gtr:impact>Sharing of CMT1A patient data and DNA</gtr:impact><gtr:outcomeId>RpFVHoJATmh-1</gtr:outcomeId><gtr:partnerContribution>Sharing of CMT1A patient data and DNA</gtr:partnerContribution><gtr:piContribution>Sharing of CMT1A patient data and DNA</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>British Medical Association (BMA)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>BMA</gtr:description><gtr:id>44D7283A-22A9-4802-A553-2C05A38A675F</gtr:id><gtr:impact>Funding and publication</gtr:impact><gtr:outcomeId>nrTBYatScPi-1</gtr:outcomeId><gtr:partnerContribution>Funding and good press for our research</gtr:partnerContribution><gtr:piContribution>Funding and publication</gtr:piContribution><gtr:sector>Learned Society</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Organization for Rare Disorders (NORD)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>NORD</gtr:description><gtr:id>E229D3F0-0044-4464-AFDA-7FD2382007B3</gtr:id><gtr:impact>Patient's referred and a grant</gtr:impact><gtr:outcomeId>nDa21vfuupd-1</gtr:outcomeId><gtr:partnerContribution>Patient's referred and a grant</gtr:partnerContribution><gtr:piContribution>Patient's referred and a grant</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC UK Brain Banks Network</gtr:department><gtr:description>European and American Brain Bank Network</gtr:description><gtr:id>F256BE14-4C92-4D8C-B335-9696609DB59E</gtr:id><gtr:impact>Publications and the addition of important tissue resources</gtr:impact><gtr:outcomeId>76D7752909A-1</gtr:outcomeId><gtr:partnerContribution>Collaborated with tissus</gtr:partnerContribution><gtr:piContribution>This collaboration has given valuable patient brain tissue to our research</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Veterinary Medicine</gtr:department><gtr:description>Cambridge collaboration on Dog ataxia and neuropathy.</gtr:description><gtr:id>72501D17-BAD6-4EE0-B416-589AD52D1E56</gtr:id><gtr:impact>Ongoing work</gtr:impact><gtr:outcomeId>TiLk1mX2EBG-1</gtr:outcomeId><gtr:partnerContribution>Dog tissue</gtr:partnerContribution><gtr:piContribution>Cambridge collaboration on Dog ataxia and neuropathy.

We are working on the genetics of neuropathy and ataxia in dog models of human disease</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Centre for Neuromuscular Diseases</gtr:department><gtr:description>MRC Centre for Neuromuscular Diseases</gtr:description><gtr:id>8583EE1F-0B82-4FBD-9F13-EA8D2F537F86</gtr:id><gtr:impact>The MRC Centre for Neuromuscular Diseases is an MRC funded centre set up to investigate the causes and identify treatments for neuromuscular diseases. I am a member and collaborator in the The MRC Centre for Neuromuscular Diseases.</gtr:impact><gtr:outcomeId>5EB6CEB5F9D-1</gtr:outcomeId><gtr:partnerContribution>The MRC Centre for Neuromuscular Diseases is an MRC funded centre set up to investigate the causes and identify treatments for neuromuscular diseases. I am a member and collaborator in the The MRC Centre for Neuromuscular Diseases.</gtr:partnerContribution><gtr:piContribution>The MRC Centre for Neuromuscular Diseases is an MRC funded centre set up to investigate the causes and identify treatments for neuromuscular diseases.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institute on Aging</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Laboratory of Neurogenetics, NIA</gtr:description><gtr:id>DEBEE20D-14FB-48F0-9F21-FCD634F77655</gtr:id><gtr:impact>Joint publications and techniques</gtr:impact><gtr:outcomeId>107C332DC25-1</gtr:outcomeId><gtr:partnerContribution>Collaboration on techniques and patients</gtr:partnerContribution><gtr:piContribution>Collaborating on techniques such as developing DNA arrays and exome sequencing in our lab</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Sanford Heart Hospital</gtr:collaboratingOrganisation><gtr:description>dystonia genetics and functional gene collaboration</gtr:description><gtr:id>853345E2-B491-4C00-A42B-0A68714D6B98</gtr:id><gtr:impact>DMRF joint grant</gtr:impact><gtr:outcomeId>JHUxh8CKWJY-1</gtr:outcomeId><gtr:partnerContribution>dystonia genetics and functional gene collaboration</gtr:partnerContribution><gtr:piContribution>Exome sequencing, fibroblast and expression studies</gtr:piContribution><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>European Commission</gtr:collaboratingOrganisation><gtr:country>European Union (EU)</gtr:country><gtr:department>EC FP6 Collaborative Projects</gtr:department><gtr:description>EUROSCA</gtr:description><gtr:id>A08C7FD4-6AD1-4DCA-AAF7-C2DCACC85F1E</gtr:id><gtr:impact>Publications as already give. Patients and clinical details of cases with ataxia</gtr:impact><gtr:outcomeId>C8022CF03BB-1</gtr:outcomeId><gtr:partnerContribution>EUROSCA is a collaboration between researchers and clinicians working on ataxia. These has brought cases and techniques that have benefited my research.</gtr:partnerContribution><gtr:piContribution>Identification, screening and functional characterization of ataxia genes</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Thessaly</gtr:collaboratingOrganisation><gtr:country>Greece, Hellenic Republic</gtr:country><gtr:department>Neurology Thessaly</gtr:department><gtr:description>Larisa Greek parkinsonism study</gtr:description><gtr:id>86846396-60F8-4E7E-871A-CF0828A6A3B0</gtr:id><gtr:impact>Over 1200 Greek parkinsonian patients and controls collected and DNA extracted.

Work ongoing, GWAS underway</gtr:impact><gtr:outcomeId>hSTdgtcyGvw-1</gtr:outcomeId><gtr:piContribution>Larisa Greek parkinsonism study.

Over 1200 Greek parkinsonian patients and controls collected and DNA extracted</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Centre for Neuromuscular Diseases</gtr:department><gtr:description>MRC NMC</gtr:description><gtr:id>1C714DD9-FD2B-4091-A464-0D36E1251BE5</gtr:id><gtr:impact>I am a member of the MRC Centre for Neuromuscular Diseases which has brought in very important collaborations between myself and Mike Hanna and Mary Reilly. We have generated considerable data, patient information and publications.</gtr:impact><gtr:outcomeId>e1whaABWaoL-1</gtr:outcomeId><gtr:partnerContribution>I am a member of the MRC Centre for Neuromuscular Diseases which has brought in very important collaborations between myself and Mike Hanna and Mary Reilly. We have generated considerable data, patient information and publications.</gtr:partnerContribution><gtr:piContribution>I am a member of the MRC Centre for Neuromuscular Diseases which has brought in very important collaborations between myself and Mike Hanna and Mary Reilly. We have generated considerable data, patient information and publications.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Partnership for Advanced Computing in Europe (PRACE)</gtr:collaboratingOrganisation><gtr:country>Belgium, Kingdom of</gtr:country><gtr:description>Synaptopathies consortium</gtr:description><gtr:id>45BFD657-7F3D-4ABB-91A8-60EC235D5809</gtr:id><gtr:impact>Built up a significant cohort</gtr:impact><gtr:outcomeId>56dda7f8d9c511.31485830-1</gtr:outcomeId><gtr:partnerContribution>Families and samples</gtr:partnerContribution><gtr:piContribution>Synaptopathies consortium: Wellcome Trust strategic award
Sequencing in paroxysmal disorders with collaboration with Rothman, Kullmann, Hanna, Sisodiya, Goadsy and others</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Neuromuscular research day</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>4C0073A4-4785-417F-A0CB-DC081B6497E5</gtr:id><gtr:impact>Around 100 patients

More patients involved in our research</gtr:impact><gtr:outcomeId>X2LAP1Nu5SH</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2007,2008,2009,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Genomics England Genome Sequencing (100,000 genomes) and Neurology GeCIP (HH is co-lead)</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>6A223DBC-2826-4710-AFE2-70037162FFE0</gtr:id><gtr:impact>Genomics England Genome Sequencing (100,000 genomes) and Neurology GeCIP (HH is co-lead)</gtr:impact><gtr:outcomeId>56dda9db80bbe3.87510799</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.genomicsengland.co.uk</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>HSP society</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>8816C232-349F-4210-876A-C64B20232ADE</gtr:id><gtr:impact>HSP yearly meet and section in HSP booklet</gtr:impact><gtr:outcomeId>k9hnMBBF1Tf</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2012,2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>980000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Strategic Award</gtr:description><gtr:end>2020-04-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:fundingRef> The Wellcome Trust (equipment and the Synaptopathies strategic award (104033/z/14/z)</gtr:fundingRef><gtr:id>9DB3C925-0BC0-4EEC-A421-DBECC2285457</gtr:id><gtr:outcomeId>56dda8c7bbcb17.45050507</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>661363</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Equipment award Wellcome Trust</gtr:description><gtr:end>2016-07-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>4E3AA74A-2E59-4C21-AA40-8F039CCD0F62</gtr:id><gtr:outcomeId>fUgJjWPHDak</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-08-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Improved and larger range of neurogenetic tests</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>7286BFB6-43EF-4094-B0B0-E75968EFC636</gtr:id><gtr:impact>Improved and larger range of neurogenetic tests. This leads to greater research and a better service for patients</gtr:impact><gtr:outcomeId>19BADAC486D</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs><gtr:productOutput><gtr:description>Development of gene panel testing in neurological disorders. This covers each clinical group of neurological disorders and will be available from January 2013 through the NHS and other outside groups at a cost basis</gtr:description><gtr:id>96A5472C-787D-4122-A9B0-03BBF64037D3</gtr:id><gtr:impact>Development of gene panel testing in neurological disorders. This covers each clinical group of neurological disorders and will be available from January 2013 through the NHS and other outside groups at a cost basis
Impacts:
1. Many more genes offered, using panels these genes are completely covered.
2. Cheaper testing
3. Faster turnaround</gtr:impact><gtr:outcomeId>qGHGwPZVLrG</gtr:outcomeId><gtr:stage>Initial development</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Development of gene panel testing in neurological disorders</gtr:title><gtr:type>Diagnostic Tool - Non-Imaging</gtr:type><gtr:yearDevCompleted>2012</gtr:yearDevCompleted></gtr:productOutput><gtr:productOutput><gtr:description>he discovery of two genes for Childhood MND have changed practice and patients are now treated with Riboflavin and new genetic tests</gtr:description><gtr:id>71060ABE-00B1-420F-A923-5E715FDF8164</gtr:id><gtr:impact>he discovery of two genes for Childhood MND have changed practice and patients are now treated with Riboflavin</gtr:impact><gtr:outcomeId>Sqcq3mUJr7e</gtr:outcomeId><gtr:stage>Initial development</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Riboflavin in MND and new gene tests</gtr:title><gtr:type>Therapeutic Intervention - Drug</gtr:type><gtr:yearDevCompleted>2012</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>Synaptopathies collaboration</gtr:description><gtr:id>C9E30AD5-062A-4C56-9A12-023C2E6DDAC0</gtr:id><gtr:impact>Synaptopathies collaboration</gtr:impact><gtr:outcomeId>56ddb2d8515fe7.79983577</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Synaptopathies collaboration</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Genome sequencing and GeCIP</gtr:description><gtr:id>FCDE2BF2-EB01-458F-BE66-EA2DC1B180C5</gtr:id><gtr:impact>Genome sequencing and GeCIP</gtr:impact><gtr:outcomeId>56ddb25982b527.74911307</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Genome sequencing and GeCIP</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:url>http://www.genomicsengland.co.uk</gtr:url><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Synaptopathies collaboration</gtr:description><gtr:id>47A85620-3E58-403F-837B-58113C0273E4</gtr:id><gtr:impact>Synaptopathies collaboration</gtr:impact><gtr:outcomeId>56ddb28f1d6eb5.21354160</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Synaptopathies collaboration</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Muscle international registry and biobank</gtr:description><gtr:id>E13951C9-71C1-4D34-9AF5-DB367101CD3C</gtr:id><gtr:impact>Muscle international registry and biobank</gtr:impact><gtr:outcomeId>edKKnP7UcCJ</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Muscle international registry and biobank</gtr:title><gtr:type>Database/Collection of Data/Biological Samples</gtr:type><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>ACDF7258-66CD-428C-A3DA-2D4C3BB487C2</gtr:id><gtr:title>Novel single base-pair deletion in exon 1 of XK gene leading to McLeod syndrome with chorea, muscle wasting, peripheral neuropathy, acanthocytosis and haemolysis.</gtr:title><gtr:parentPublicationTitle>Journal of the neurological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f412cc6b7d29c6e9685797bea1d962d2"><gtr:id>f412cc6b7d29c6e9685797bea1d962d2</gtr:id><gtr:otherNames>Wiethoff S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-510X</gtr:issn><gtr:outcomeId>546297419ac958.95671858</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BD6B0642-2121-4289-91F1-0BC346273BFC</gtr:id><gtr:title>Genetic dysfunction of MT-ATP6 causes axonal Charcot-Marie-Tooth disease.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6459db0fb97de13ef30ce2614b06cb4a"><gtr:id>6459db0fb97de13ef30ce2614b06cb4a</gtr:id><gtr:otherNames>Pitceathly RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>pm_15519_29_22933740</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B31A19E5-2AAD-4A28-8894-45E5E424CDA4</gtr:id><gtr:title>Clinical features, with video documentation, of the original familial lewy body parkinsonism caused by a-synuclein triplication (Iowa kindred).</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c08488767bed9cf7a157d98487dc252a"><gtr:id>c08488767bed9cf7a157d98487dc252a</gtr:id><gtr:otherNames>Gwinn K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>KTFp2UKQd6k</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>081704AF-D750-45E7-8831-07EB387997C3</gtr:id><gtr:title>A novel ABCD1 mutation detected by next generation sequencing in presumed hereditary spastic paraplegia: A 30-year diagnostic delay caused by misleading biochemical findings.</gtr:title><gtr:parentPublicationTitle>Journal of the neurological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a0141d4dc212d3dc1de00d97ceee75f7"><gtr:id>a0141d4dc212d3dc1de00d97ceee75f7</gtr:id><gtr:otherNames>Koutsis G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-510X</gtr:issn><gtr:outcomeId>56a40969f26c91.18516731</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A72A5AD7-65E6-42CD-9A0D-06519786ABBA</gtr:id><gtr:title>Large C9orf72 hexanucleotide repeat expansions are seen in multiple neurodegenerative syndromes and are more frequent than expected in the UK population.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/72f7fb44cb0e9d3dbae03fa9e859951a"><gtr:id>72f7fb44cb0e9d3dbae03fa9e859951a</gtr:id><gtr:otherNames>Beck J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>pm_15519_29_23434116</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>27E65AD5-65ED-40D3-9660-3B743216DE35</gtr:id><gtr:title>Late-onset Lafora disease with prominent parkinsonism due to a rare mutation in EPM2A.</gtr:title><gtr:parentPublicationTitle>Neurology. Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6867986db8e51578e846cfba3cd72c66"><gtr:id>6867986db8e51578e846cfba3cd72c66</gtr:id><gtr:otherNames>Lynch DS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2376-7839</gtr:issn><gtr:outcomeId>58c7eec828ccf7.78367357</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8DA32AA4-4A6C-4188-93E2-A3F0ECB5C779</gtr:id><gtr:title>The 4H syndrome due to RNF216 mutation.</gtr:title><gtr:parentPublicationTitle>Parkinsonism &amp; related disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6b7ff253acba98dc4017e32a051ce3e9"><gtr:id>6b7ff253acba98dc4017e32a051ce3e9</gtr:id><gtr:otherNames>Ganos C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1353-8020</gtr:issn><gtr:outcomeId>56a4096929de00.06116410</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5C854388-4E79-444C-9BF3-34880D268F13</gtr:id><gtr:title>c-Jun expression in human neuropathies: a pilot study.</gtr:title><gtr:parentPublicationTitle>Journal of the peripheral nervous system : JPNS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6439b399512804b313ce7684f719df42"><gtr:id>6439b399512804b313ce7684f719df42</gtr:id><gtr:otherNames>Hutton EJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1085-9489</gtr:issn><gtr:outcomeId>pm_15519_29_22176144</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0B517B6A-1B92-4A0D-8E21-8C93FDDCE9AE</gtr:id><gtr:title>Madras motor neuron disease (MMND) is distinct from the riboflavin transporter genetic defects that cause Brown-Vialetto-Van Laere syndrome.</gtr:title><gtr:parentPublicationTitle>Journal of the neurological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2a2993fc77ed42ab56e9055e6aaaf4cc"><gtr:id>2a2993fc77ed42ab56e9055e6aaaf4cc</gtr:id><gtr:otherNames>Nalini A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-510X</gtr:issn><gtr:outcomeId>pm_15519_29_24139842</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C5798A5F-8936-41A4-B62E-8E9420982288</gtr:id><gtr:title>A novel mutation in the nerve-specific 5'UTR of the GJB1 gene causes X-linked Charcot-Marie-Tooth disease.</gtr:title><gtr:parentPublicationTitle>Journal of the peripheral nervous system : JPNS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6742175c859dc2842759f84e6dd6f0e6"><gtr:id>6742175c859dc2842759f84e6dd6f0e6</gtr:id><gtr:otherNames>Murphy SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1085-9489</gtr:issn><gtr:outcomeId>Y1uWFcVoWXt</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>11807C29-3312-4476-9599-C625F267C401</gtr:id><gtr:title>Concomitant progressive supranuclear palsy and chronic traumatic encephalopathy in a boxer.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/79c943d719ca6749410f754081f54667"><gtr:id>79c943d719ca6749410f754081f54667</gtr:id><gtr:otherNames>Ling H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2051-5960</gtr:issn><gtr:outcomeId>54629741bd8da2.69740288</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B1FA01EA-C720-4F08-A1BD-D3AEB5E14EA2</gtr:id><gtr:title>Defects of mutant DNMT1 are linked to a spectrum of neurological disorders.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f0a851b1e66126a42944d2b038e10b89"><gtr:id>f0a851b1e66126a42944d2b038e10b89</gtr:id><gtr:otherNames>Baets J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>56a4096cd137c6.92269926</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>70414C19-49D4-4A20-BC08-2F05B444B1FE</gtr:id><gtr:title>Genome-wide estimate of the heritability of Multiple System Atrophy.</gtr:title><gtr:parentPublicationTitle>Parkinsonism &amp; related disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5bb0da6bb7eb8d81a012bd35afacacdc"><gtr:id>5bb0da6bb7eb8d81a012bd35afacacdc</gtr:id><gtr:otherNames>Federoff M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1353-8020</gtr:issn><gtr:outcomeId>56a40966495aa4.19373958</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>925BFC9C-776F-40FC-B9F5-B5644E3ACEED</gtr:id><gtr:title>Cerebral small vessel disease-related protease HtrA1 processes latent TGF-? binding protein 1 and facilitates TGF-? signaling.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/128b97c9a0949e6460aade7db5f751eb"><gtr:id>128b97c9a0949e6460aade7db5f751eb</gtr:id><gtr:otherNames>Beaufort N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>54629744bb0a73.11225902</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7A587D1A-322B-4C70-B404-34BEA79E6C7B</gtr:id><gtr:title>Mutations in ? adducin are associated with inherited cerebral palsy.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1f031c0b2f78e03012bc542323de4d08"><gtr:id>1f031c0b2f78e03012bc542323de4d08</gtr:id><gtr:otherNames>Kruer MC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>pm_15519_29_23836506</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>085C4958-9B8A-463D-B980-4B9D3827666B</gtr:id><gtr:title>Ongoing developments in sporadic inclusion body myositis.</gtr:title><gtr:parentPublicationTitle>Current rheumatology reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/973fa2ad4c5615dcdcf432bf2cfb16da"><gtr:id>973fa2ad4c5615dcdcf432bf2cfb16da</gtr:id><gtr:otherNames>Machado PM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1523-3774</gtr:issn><gtr:outcomeId>56a4096e869015.28963566</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C5A81718-5F65-4210-A294-71E7AB56B44F</gtr:id><gtr:title>A novel p.Gln175X [corrected] premature stop mutation in the C-terminal end of HSP27 is a cause of CMT2.</gtr:title><gtr:parentPublicationTitle>Journal of the peripheral nervous system : JPNS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8e200f814262dac4d6b88ac30584c047"><gtr:id>8e200f814262dac4d6b88ac30584c047</gtr:id><gtr:otherNames>Rossor AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1085-9489</gtr:issn><gtr:outcomeId>pm_15519_29_22734906</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>11764E5E-9E64-4E41-989D-8BD2AD77FDFA</gtr:id><gtr:title>The genetics and neuropathology of Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3544c3d604dfbcaee394d9a12def7ab8"><gtr:id>3544c3d604dfbcaee394d9a12def7ab8</gtr:id><gtr:otherNames>Houlden H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn><gtr:outcomeId>pm_15519_29_22806825</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CC8458FD-A3BF-47FC-BFFB-2FFE8313BBD8</gtr:id><gtr:title>Rare variants in SQSTM1 and VCP genes and risk of sporadic inclusion body myositis.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5740d7dfacf41317fd1190662cfe9c79"><gtr:id>5740d7dfacf41317fd1190662cfe9c79</gtr:id><gtr:otherNames>Gang Q</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>58c7eec75b4974.11468102</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7C5D865D-BF52-46E8-AFBF-D0A8D2ABE37F</gtr:id><gtr:title>Exome sequencing expands the mutational spectrum of SPG8 in a family with spasticity responsive to L-DOPA treatment.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9960cd808582e52821f0e586e2ba9176"><gtr:id>9960cd808582e52821f0e586e2ba9176</gtr:id><gtr:otherNames>Bettencourt C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>pm_15519_29_23881105</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5F13905A-BB35-4E61-843A-000C615754DE</gtr:id><gtr:title>Parkinson's disease in GTP cyclohydrolase 1 mutation carriers.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ed0f28b35d5e4240d5af6d917b092bf"><gtr:id>8ed0f28b35d5e4240d5af6d917b092bf</gtr:id><gtr:otherNames>Mencacci NE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>5462974302d6a4.17325265</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E3BA03F7-DF0B-4EDE-A34A-045BA6C1043F</gtr:id><gtr:title>Multiple system atrophy and repeat expansions in C9orf72.</gtr:title><gtr:parentPublicationTitle>JAMA neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ff2cda0ff39441e9d379b03cb269851"><gtr:id>3ff2cda0ff39441e9d379b03cb269851</gtr:id><gtr:otherNames>Schottlaender LV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2168-6149</gtr:issn><gtr:outcomeId>54629744015a89.26798603</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EBECF1BF-9253-4D55-BDB2-2218755E0553</gtr:id><gtr:title>Autosomal-recessive cerebellar ataxia caused by a novel ADCK3 mutation that elongates the protein: clinical, genetic and biochemical characterisation.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/75880868018d92d0b7d54e2c82d1b2bc"><gtr:id>75880868018d92d0b7d54e2c82d1b2bc</gtr:id><gtr:otherNames>Liu YT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>5462974073c8c0.14968936</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2FC575BC-2FFC-4929-9B5F-19929494AB7D</gtr:id><gtr:title>A novel a-synuclein missense mutation in Parkinson disease.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ad6d814d95a541c7e3a165cbafd92058"><gtr:id>ad6d814d95a541c7e3a165cbafd92058</gtr:id><gtr:otherNames>Proukakis C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>pm_15519_29_23427326</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C400045E-1696-4ED6-AB57-EF9EC0852DD8</gtr:id><gtr:title>VPS13C-Another Hint at Mitochondrial Dysfunction in Familial Parkinson's Disease.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f2de2cd48d9052ac53c03db9958be261"><gtr:id>f2de2cd48d9052ac53c03db9958be261</gtr:id><gtr:otherNames>Schreglmann SR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>58c7eec4daa478.57365655</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2FBFF11A-E837-45DF-9A03-0B4941D49E40</gtr:id><gtr:title>Review: genetics and neuropathology of primary pure dystonia.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b2ac56d4a5087705921cb2ad66bb2a3"><gtr:id>9b2ac56d4a5087705921cb2ad66bb2a3</gtr:id><gtr:otherNames>Paudel R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>pm_15519_29_22897341</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>30283231-812C-41BB-B4DE-63C2DEF71DD8</gtr:id><gtr:title>Genetic screening of Greek patients with Huntington's disease phenocopies identifies an SCA8 expansion.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a0141d4dc212d3dc1de00d97ceee75f7"><gtr:id>a0141d4dc212d3dc1de00d97ceee75f7</gtr:id><gtr:otherNames>Koutsis G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>pm_15519_29_22297462</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1DE95143-172A-4AF0-963B-F14108772E05</gtr:id><gtr:title>Investigation of next-generation sequencing technologies as a diagnostic tool for amyotrophic lateral sclerosis.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aa2841aab396cd2b4f18a94e7a29ae23"><gtr:id>aa2841aab396cd2b4f18a94e7a29ae23</gtr:id><gtr:otherNames>Morgan S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>56a4096d352552.37092377</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AF2BD79C-0980-4232-A112-7BB9C234653C</gtr:id><gtr:title>A practical approach to diagnosing adult onset leukodystrophies.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf826f577934fec360780ebfe7e1b870"><gtr:id>cf826f577934fec360780ebfe7e1b870</gtr:id><gtr:otherNames>Ahmed RM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>54629740ad06a5.13382899</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>23DC5D3E-3022-431D-A523-9A25142058B1</gtr:id><gtr:title>A novel NGF mutation clarifies the molecular mechanism and extends the phenotypic spectrum of the HSAN5 neuropathy.</gtr:title><gtr:parentPublicationTitle>Journal of medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/76e00af3054632a7f1e9c1cff9e43c54"><gtr:id>76e00af3054632a7f1e9c1cff9e43c54</gtr:id><gtr:otherNames>Carvalho OP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-2593</gtr:issn><gtr:outcomeId>sFBe5gXzu2w</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A67663F8-A159-4737-A6B3-282855167A44</gtr:id><gtr:title>Erratum to: Charcot-Marie-Tooth disease type 2C and scapuloperoneal muscular atrophy overlap syndrome in a patient with the R232C TRPV4 mutation.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a0141d4dc212d3dc1de00d97ceee75f7"><gtr:id>a0141d4dc212d3dc1de00d97ceee75f7</gtr:id><gtr:otherNames>Koutsis G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>56a40969bf4392.93812018</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C1679DF2-6FC3-4BBA-82E9-FB0053BFFFD4</gtr:id><gtr:title>Extending the clinical spectrum of pain channelopathies.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3544c3d604dfbcaee394d9a12def7ab8"><gtr:id>3544c3d604dfbcaee394d9a12def7ab8</gtr:id><gtr:otherNames>Houlden H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>pm_15519_29_22345085</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>59D57EBE-3BAE-424F-AFBF-96CDC64B1214</gtr:id><gtr:title>H-ABC syndrome and DYT4: Variable expressivity or pleiotropy of TUBB4 mutations?</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fc98b863ea1e6ac2e57978c77cd38ad6"><gtr:id>fc98b863ea1e6ac2e57978c77cd38ad6</gtr:id><gtr:otherNames>Erro R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>56a4096c710168.69605258</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>19CA2224-D2CD-448F-B0C5-C1949DADB8B4</gtr:id><gtr:title>C19orf12 mutation leads to a pallido-pyramidal syndrome.</gtr:title><gtr:parentPublicationTitle>Gene</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1f031c0b2f78e03012bc542323de4d08"><gtr:id>1f031c0b2f78e03012bc542323de4d08</gtr:id><gtr:otherNames>Kruer MC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0378-1119</gtr:issn><gtr:outcomeId>54629741038135.22563328</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EDA8874A-9F5F-4D70-807C-88A0DB4A990F</gtr:id><gtr:title>Polymyositis without Beneficial Response to Steroid Therapy: Should Miyoshi Myopathy be a Differential Diagnosis?</gtr:title><gtr:parentPublicationTitle>The American journal of case reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb7de9e0bdbda47bf81b86f2720f04e3"><gtr:id>bb7de9e0bdbda47bf81b86f2720f04e3</gtr:id><gtr:otherNames>Scalco RS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1941-5923</gtr:issn><gtr:outcomeId>58c7eec5ed6688.74304587</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D6D4B765-0492-49FA-BA75-7C452FA666F8</gtr:id><gtr:title>Hereditary sensory and autonomic neuropathy type 1 (HSANI) caused by a novel mutation in SPTLC2.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6742175c859dc2842759f84e6dd6f0e6"><gtr:id>6742175c859dc2842759f84e6dd6f0e6</gtr:id><gtr:otherNames>Murphy SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>pm_15519_29_23658386</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4207EED5-AC1A-47DD-96A9-84F422F7C4C3</gtr:id><gtr:title>Novel peripheral myelin protein 22 (PMP22) micromutations associated with variable phenotypes in Greek patients with Charcot-Marie-Tooth disease.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a0141d4dc212d3dc1de00d97ceee75f7"><gtr:id>a0141d4dc212d3dc1de00d97ceee75f7</gtr:id><gtr:otherNames>Koutsis G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>pm_15519_29_22382358</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AF243C7A-DB41-4F64-BED8-A2057E6B25BC</gtr:id><gtr:title>A 30-unit hexanucleotide repeat expansion in C9orf72 induces pathological lesions with dipeptide-repeat proteins and RNA foci, but not TDP-43 inclusions and clinical disease.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1a0840fa64698c2bea936eb7c3ca6bc7"><gtr:id>1a0840fa64698c2bea936eb7c3ca6bc7</gtr:id><gtr:otherNames>Gami P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn><gtr:outcomeId>56a40967b7bf46.28979690</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DD3D2E0A-2FFA-4C52-A595-10310C51B1C4</gtr:id><gtr:title>Faulty cardiac repolarization reserve in alternating hemiplegia of childhood broadens the phenotype.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/159c8c7cefbd596fac1d4f5555aa91ee"><gtr:id>159c8c7cefbd596fac1d4f5555aa91ee</gtr:id><gtr:otherNames>Jaffer F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>56a40967eb2611.14469790</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>276434A1-F673-4C58-B479-3C0D9E0FA04D</gtr:id><gtr:title>Call for participation in the neurogenetics consortium within the Human Variome Project.</gtr:title><gtr:parentPublicationTitle>Neurogenetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf0a954d1d5828f1ecd056a80ce34553"><gtr:id>cf0a954d1d5828f1ecd056a80ce34553</gtr:id><gtr:otherNames>Haworth A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1364-6745</gtr:issn><gtr:outcomeId>UijPrNfkLdo</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>597898DE-C935-42B8-A857-280A55EA7A66</gtr:id><gtr:title>Gene co-expression networks shed light into diseases of brain iron accumulation.</gtr:title><gtr:parentPublicationTitle>Neurobiology of disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9960cd808582e52821f0e586e2ba9176"><gtr:id>9960cd808582e52821f0e586e2ba9176</gtr:id><gtr:otherNames>Bettencourt C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0969-9961</gtr:issn><gtr:outcomeId>56a409667a5ab9.40053577</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0D054BEC-3F3E-4532-86E8-8420734467F8</gtr:id><gtr:title>Peripheral neuropathy predicts nuclear gene defect in patients with mitochondrial ophthalmoplegia.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70045987ef050d49a7a1c26b398ecd06"><gtr:id>70045987ef050d49a7a1c26b398ecd06</gtr:id><gtr:otherNames>Horga A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>54629744516a73.55359918</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A32A6FEE-F2FD-48DE-9298-D4E0C082B75E</gtr:id><gtr:title>Mutations in SLC39A14 disrupt manganese homeostasis and cause childhood-onset parkinsonism-dystonia.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fa078abc03e0426b87406530fac025ca"><gtr:id>fa078abc03e0426b87406530fac025ca</gtr:id><gtr:otherNames>Tuschl K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>58c7eec57a22a8.75008271</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F2F55E3E-1B4E-427A-88BD-4F25DBC9DAE1</gtr:id><gtr:title>Review: Insights into molecular mechanisms of disease in neurodegeneration with brain iron accumulation: unifying theories.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/33fdd530dd8d5783625da53463d9f727"><gtr:id>33fdd530dd8d5783625da53463d9f727</gtr:id><gtr:otherNames>Arber CE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>56a4096d069932.30978528</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>87B03FA8-CCF3-449A-A6C2-34820C4A69AB</gtr:id><gtr:title>Clinical features of childhood-onset paroxysmal kinesigenic dyskinesia with PRRT2 gene mutations.</gtr:title><gtr:parentPublicationTitle>Developmental medicine and child neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/961fb7c7b58bf324f312f76fae2f3a64"><gtr:id>961fb7c7b58bf324f312f76fae2f3a64</gtr:id><gtr:otherNames>Silveira-Moriyama L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0012-1622</gtr:issn><gtr:outcomeId>pm_15519_29_23363396</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1BC43282-B317-47F0-9AF7-012761304AF5</gtr:id><gtr:title>Benefit of carbamazepine in a patient with hemiplegic migraine associated with PRRT2 mutation.</gtr:title><gtr:parentPublicationTitle>Developmental medicine and child neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/191a34cadb34bb04b665c6b4cd8bed4b"><gtr:id>191a34cadb34bb04b665c6b4cd8bed4b</gtr:id><gtr:otherNames>Dale RC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0012-1622</gtr:issn><gtr:outcomeId>5462974176f2d6.36262943</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D79A8E6C-401E-4BC0-9D93-AFA7ADBC7885</gtr:id><gtr:title>Analysis of Parkinson's disease brain-derived DNA for alpha-synuclein coding somatic mutations.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ad6d814d95a541c7e3a165cbafd92058"><gtr:id>ad6d814d95a541c7e3a165cbafd92058</gtr:id><gtr:otherNames>Proukakis C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>546297423a3570.64051165</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4CCF3A13-0744-4D3D-A72B-81C0FF2E4D7F</gtr:id><gtr:title>NDUFA4 mutations underlie dysfunction of a cytochrome c oxidase subunit linked to human neurological disease.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6459db0fb97de13ef30ce2614b06cb4a"><gtr:id>6459db0fb97de13ef30ce2614b06cb4a</gtr:id><gtr:otherNames>Pitceathly RD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>pm_15519_29_23746447</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B87B5794-709D-4BEA-AB79-82123B31096E</gtr:id><gtr:title>Kjellin syndrome: hereditary spastic paraplegia with pathognomonic macular appearance.</gtr:title><gtr:parentPublicationTitle>Practical neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3dab0e4563cc38ec8a53385853a2437b"><gtr:id>3dab0e4563cc38ec8a53385853a2437b</gtr:id><gtr:otherNames>Nowak VA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1474-7758</gtr:issn><gtr:outcomeId>54629742a8e222.00852509</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1143E768-611B-4A7F-A766-1906ED5E20C5</gtr:id><gtr:title>Spinocerebellar ataxia type 11.</gtr:title><gtr:parentPublicationTitle>Handbook of clinical neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b2df3bc2ec28ba7b9d1138e19fcb25ea"><gtr:id>b2df3bc2ec28ba7b9d1138e19fcb25ea</gtr:id><gtr:otherNames>Giunti P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0072-9752</gtr:issn><gtr:outcomeId>sNQHseaGAfv</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>09DBAA1E-2153-47DA-A9A4-A0A535BCEC6A</gtr:id><gtr:title>Young-onset parkinsonism due to homozygous duplication of a-synuclein in a consanguineous family.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a710ca1824f44073ef7bb8d23ab87321"><gtr:id>a710ca1824f44073ef7bb8d23ab87321</gtr:id><gtr:otherNames>Kojovic M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>pm_15519_29_23283657</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>29CBE071-457D-4ECE-BF0D-421950368BC9</gtr:id><gtr:title>Recessive axonal Charcot-Marie-Tooth disease due to compound heterozygous mitofusin 2 mutations.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ea6cf7f32ce5138c0346fdb7615e95bc"><gtr:id>ea6cf7f32ce5138c0346fdb7615e95bc</gtr:id><gtr:otherNames>Polke JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>puCrTB5D7kF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E3A67C8F-35A9-43F5-83E5-E2E0A23D1217</gtr:id><gtr:title>HLA-DRB*1501 associations with magnetic resonance imaging measures of grey matter pathology in multiple sclerosis.</gtr:title><gtr:parentPublicationTitle>Multiple sclerosis and related disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c05a2a09474056b5d5c18a55d9bd46c8"><gtr:id>c05a2a09474056b5d5c18a55d9bd46c8</gtr:id><gtr:otherNames>Yaldizli ?</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2211-0348</gtr:issn><gtr:outcomeId>58c7eec9e88021.71288858</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>62773B90-011A-4686-9015-426BB38EDD5E</gtr:id><gtr:title>The phenotypic spectrum of DYT24 due to ANO3 mutations.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d3b37a1ea4c6bb2dd69d484101a8d28c"><gtr:id>d3b37a1ea4c6bb2dd69d484101a8d28c</gtr:id><gtr:otherNames>Stamelou M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>54629741509c27.07505633</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E8643BB1-32D3-496E-8EC5-68A930F5DE55</gtr:id><gtr:title>A Commentary on 'Four novel C20ORF54 mutations identified in Brown-Vialetto-Van Laere syndrome patients.'.</gtr:title><gtr:parentPublicationTitle>Journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3544c3d604dfbcaee394d9a12def7ab8"><gtr:id>3544c3d604dfbcaee394d9a12def7ab8</gtr:id><gtr:otherNames>Houlden H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1434-5161</gtr:issn><gtr:outcomeId>pm_15519_29_22786578</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>973F0295-FA7B-4C85-A96E-A58AF7079C42</gtr:id><gtr:title>DNA repair pathways underlie a common genetic mechanism modulating onset in polyglutamine diseases.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9960cd808582e52821f0e586e2ba9176"><gtr:id>9960cd808582e52821f0e586e2ba9176</gtr:id><gtr:otherNames>Bettencourt C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>58c7eec983ff40.65236389</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7017D51A-BF45-42D0-B130-4EB473232E90</gtr:id><gtr:title>De Novo Mutations in PDE10A Cause Childhood-Onset Chorea with Bilateral Striatal Lesions.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ed0f28b35d5e4240d5af6d917b092bf"><gtr:id>8ed0f28b35d5e4240d5af6d917b092bf</gtr:id><gtr:otherNames>Mencacci NE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>58c7eeca21b045.36026166</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4B737CEB-51CC-4D5D-A770-3C58FF95621E</gtr:id><gtr:title>X inactivation in females with X-linked Charcot-Marie-Tooth disease.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6742175c859dc2842759f84e6dd6f0e6"><gtr:id>6742175c859dc2842759f84e6dd6f0e6</gtr:id><gtr:otherNames>Murphy SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>pm_15519_29_22483671</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4DF449D3-07D3-4B76-9CB4-AB68722D4A98</gtr:id><gtr:title>Homozygous mutations in VAMP1 cause a presynaptic congenital myasthenic syndrome.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c12954aa30a8fba72f3439d776bda00b"><gtr:id>c12954aa30a8fba72f3439d776bda00b</gtr:id><gtr:otherNames>Salpietro V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>58c7eec25ec5b2.59299037</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6F2F5887-5EB1-43B7-AB4B-E546247C7009</gtr:id><gtr:title>Rapidly progressive asymmetrical weakness in Charcot-Marie-Tooth disease type 4J resembles chronic inflammatory demyelinating polyneuropathy.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bcb877e01dd9f33040f7fc09646ce4b6"><gtr:id>bcb877e01dd9f33040f7fc09646ce4b6</gtr:id><gtr:otherNames>Cottenie E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>pm_15519_29_23489662</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>63F7EC23-957F-4C77-B046-2B29AABAB5C3</gtr:id><gtr:title>Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf8b293c57e2abbe75629b0924e21ef0"><gtr:id>cf8b293c57e2abbe75629b0924e21ef0</gtr:id><gtr:otherNames>Nalls MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>54629743784bd7.47978520</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>83123840-3285-4821-9C98-C6BFB74856C3</gtr:id><gtr:title>Identical twins with Leucine rich repeat kinase type 2 mutations discordant for Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7683c72a503be0311ba813667c505f75"><gtr:id>7683c72a503be0311ba813667c505f75</gtr:id><gtr:otherNames>Xiromerisiou G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>pm_15519_29_22488887</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>15D566DD-E622-45B8-86F2-ABB3719D7916</gtr:id><gtr:title>Analysis of Mutations in AARS2 in a Series of CSF1R-Negative Patients With Adult-Onset Leukoencephalopathy With Axonal Spheroids and Pigmented Glia.</gtr:title><gtr:parentPublicationTitle>JAMA neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6867986db8e51578e846cfba3cd72c66"><gtr:id>6867986db8e51578e846cfba3cd72c66</gtr:id><gtr:otherNames>Lynch DS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2168-6149</gtr:issn><gtr:outcomeId>58c7eec71d4765.83547065</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C278B229-695F-4F4C-B4F9-69012F8EC424</gtr:id><gtr:title>Exome sequencing reveals de novo WDR45 mutations causing a phenotypically distinct, X-linked dominant form of NBIA.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/35d3a74312ac86d45efc47ac78a3c98c"><gtr:id>35d3a74312ac86d45efc47ac78a3c98c</gtr:id><gtr:otherNames>Haack TB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>pm_15519_29_23176820</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2820C322-625D-4F73-902C-830B4BA470E0</gtr:id><gtr:title>Mutation in FAM134B causing severe hereditary sensory neuropathy.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6742175c859dc2842759f84e6dd6f0e6"><gtr:id>6742175c859dc2842759f84e6dd6f0e6</gtr:id><gtr:otherNames>Murphy SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>pm_15519_29_21115472</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>35071165-5890-4179-AC9E-312B04DA2E92</gtr:id><gtr:title>Parkinson's disease induced pluripotent stem cells with triplication of the a-synuclein locus.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/81b016b620411b3da51cfd468ebe3c2a"><gtr:id>81b016b620411b3da51cfd468ebe3c2a</gtr:id><gtr:otherNames>Devine MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>c9Zqxp6snpK</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>754CA968-7F8A-4E01-A7FD-30CBD5035569</gtr:id><gtr:title>CAV3 mutations causing exercise intolerance, myalgia and rhabdomyolysis: Expanding the phenotypic spectrum of caveolinopathies.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb7de9e0bdbda47bf81b86f2720f04e3"><gtr:id>bb7de9e0bdbda47bf81b86f2720f04e3</gtr:id><gtr:otherNames>Scalco RS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>58c7eec8527fc2.35446189</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4DCF5B3C-8D77-440D-958E-A7B4C63BC2BD</gtr:id><gtr:title>The neuropathology, pathophysiology and genetics of multiple system atrophy.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/699401602f933276abda64770fc6df19"><gtr:id>699401602f933276abda64770fc6df19</gtr:id><gtr:otherNames>Ahmed Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>RY4bhnURF54</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F402A9E4-4BD0-4B7F-9806-A551B0013288</gtr:id><gtr:title>Heterogeneity in clinical features and disease severity in ataxia-associated SYNE1 mutations.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f412cc6b7d29c6e9685797bea1d962d2"><gtr:id>f412cc6b7d29c6e9685797bea1d962d2</gtr:id><gtr:otherNames>Wiethoff S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>58c7eec516ddb9.24620014</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E92872C8-773C-4715-B41A-D3ADCCD60DDC</gtr:id><gtr:title>A dominant mutation in FBXO38 causes distal spinal muscular atrophy with calf predominance.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5f5c596058f4e99b11d3fe3dbd4f968f"><gtr:id>5f5c596058f4e99b11d3fe3dbd4f968f</gtr:id><gtr:otherNames>Sumner CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>54629740205172.11003535</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4545C939-AFB5-4EB9-A260-BFAD865E963E</gtr:id><gtr:title>Mutational analysis of PMP22, EGR2, LITAF and NEFL in Greek Charcot-Marie-Tooth type 1 patients.</gtr:title><gtr:parentPublicationTitle>Clinical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a0141d4dc212d3dc1de00d97ceee75f7"><gtr:id>a0141d4dc212d3dc1de00d97ceee75f7</gtr:id><gtr:otherNames>Koutsis G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0009-9163</gtr:issn><gtr:outcomeId>pm_15519_29_22765307</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>57145A5B-86CC-4353-8182-F23C00641C4C</gtr:id><gtr:title>Genetic and phenotypic characterization of complex hereditary spastic paraplegia.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/697536feebefd233256c0907479ff552"><gtr:id>697536feebefd233256c0907479ff552</gtr:id><gtr:otherNames>Kara E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>58c7eec8c24b74.65858354</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>172A5B97-CCDF-494A-A723-7792F78A2AC4</gtr:id><gtr:title>Treatable childhood neuronopathy caused by mutations in riboflavin transporter RFVT2.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/79ba297a1edd6970078cb545704ad890"><gtr:id>79ba297a1edd6970078cb545704ad890</gtr:id><gtr:otherNames>Foley AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>pm_540e168e1680c0b01</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>53FD08F0-B254-45B8-91B7-79790EC969F2</gtr:id><gtr:title>Novel C12orf65 mutations in patients with axonal neuropathy and optic atrophy.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2e8088f2d6e90105cd78b127c6516c9f"><gtr:id>2e8088f2d6e90105cd78b127c6516c9f</gtr:id><gtr:otherNames>Tucci A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>pm_15519_29_24198383</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>29565D3F-7DB6-4DE7-9BD0-CA6D233B2ACC</gtr:id><gtr:title>De novo KCNA2 mutations cause hereditary spastic paraplegia.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c9ffda67425e994f02c670de63593986"><gtr:id>c9ffda67425e994f02c670de63593986</gtr:id><gtr:otherNames>Manole A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>58c7eec2cc5450.84221112</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>903AE07A-5FD8-4D13-A223-ABDEC21006A1</gtr:id><gtr:title>Verification of Inter-laboratorial Genotyping Consistency in the Molecular Diagnosis of Polyglutamine Spinocerebellar Ataxias.</gtr:title><gtr:parentPublicationTitle>Journal of molecular neuroscience : MN</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f7ca917b7a90a50ab88287e6b9367286"><gtr:id>f7ca917b7a90a50ab88287e6b9367286</gtr:id><gtr:otherNames>Ramos A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0895-8696</gtr:issn><gtr:outcomeId>56a40968a53572.88065710</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5351F13B-05CB-43F3-A583-78295852228B</gtr:id><gtr:title>Familial PRRT2 mutation with heterogeneous paroxysmal disorders including paroxysmal torticollis and hemiplegic migraine.</gtr:title><gtr:parentPublicationTitle>Developmental medicine and child neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/191a34cadb34bb04b665c6b4cd8bed4b"><gtr:id>191a34cadb34bb04b665c6b4cd8bed4b</gtr:id><gtr:otherNames>Dale RC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0012-1622</gtr:issn><gtr:outcomeId>pm_15519_29_22845787</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0CF2F53F-9633-400D-8DF2-EFC357B2F39F</gtr:id><gtr:title>Frequency of mutations in the genes associated with hereditary sensory and autonomic neuropathy in a UK cohort.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bd4fe90f775f7ad2b26d983c719e78eb"><gtr:id>bd4fe90f775f7ad2b26d983c719e78eb</gtr:id><gtr:otherNames>Davidson G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>pm_15519_29_22302274</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1A439775-E9B9-4392-8413-F84955FD8C69</gtr:id><gtr:title>Comprehensive analysis of the TRPV4 gene in a large series of inherited neuropathies and controls.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b9db8397000487616b1a525abb470315"><gtr:id>b9db8397000487616b1a525abb470315</gtr:id><gtr:otherNames>Fawcett KA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>pm_15519_29_22851605</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C2FF701C-36B8-4E3C-A349-585E80C75ACF</gtr:id><gtr:title>Neuropathology of Beta-propeller protein associated neurodegeneration (BPAN): a new tauopathy.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b2ac56d4a5087705921cb2ad66bb2a3"><gtr:id>9b2ac56d4a5087705921cb2ad66bb2a3</gtr:id><gtr:otherNames>Paudel R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2051-5960</gtr:issn><gtr:outcomeId>56a4096b19f498.12889417</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D7C19322-C6AA-4A08-AE37-4B8B5F3F368E</gtr:id><gtr:title>Dystonic opisthotonus: a &amp;quot;red flag&amp;quot; for neurodegeneration with brain iron accumulation syndromes?</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d3b37a1ea4c6bb2dd69d484101a8d28c"><gtr:id>d3b37a1ea4c6bb2dd69d484101a8d28c</gtr:id><gtr:otherNames>Stamelou M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>pm_15519_29_23736975</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>209EE167-13F8-4EEE-96AC-B0235F7F24C3</gtr:id><gtr:title>Defects of RNA metabolism in the pathogenesis of spinal muscular atrophy.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bd4d0f80718b51ee04d0d4b40400c130"><gtr:id>bd4d0f80718b51ee04d0d4b40400c130</gtr:id><gtr:otherNames>Bertini E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>5462974213b6c9.14520346</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>77C6AE44-BDE1-45D6-90A2-EBBF964C7166</gtr:id><gtr:title>Myoclonus-dystonia syndrome due to tyrosine hydroxylase deficiency.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d3b37a1ea4c6bb2dd69d484101a8d28c"><gtr:id>d3b37a1ea4c6bb2dd69d484101a8d28c</gtr:id><gtr:otherNames>Stamelou M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>pm_15519_29_22815559</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A243F8B6-7696-4FAB-8903-D72D4231278E</gtr:id><gtr:title>Mutant COQ2 in multiple-system atrophy.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ff2cda0ff39441e9d379b03cb269851"><gtr:id>3ff2cda0ff39441e9d379b03cb269851</gtr:id><gtr:otherNames>Schottlaender LV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>54629742cf5770.72842901</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C8125E52-965F-4446-BAAE-AA4F8947B89D</gtr:id><gtr:title>Coenzyme Q10 Levels Are Decreased in the Cerebellum of Multiple-System Atrophy Patients.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ff2cda0ff39441e9d379b03cb269851"><gtr:id>3ff2cda0ff39441e9d379b03cb269851</gtr:id><gtr:otherNames>Schottlaender LV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>585d52e9b420e5.71535099</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>83A04F2A-7F5D-410C-A778-68A315D68554</gtr:id><gtr:title>Neuroimaging features of neurodegeneration with brain iron accumulation.</gtr:title><gtr:parentPublicationTitle>AJNR. American journal of neuroradiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1f031c0b2f78e03012bc542323de4d08"><gtr:id>1f031c0b2f78e03012bc542323de4d08</gtr:id><gtr:otherNames>Kruer MC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0195-6108</gtr:issn><gtr:outcomeId>pm_15519_29_21920862</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BE6991C1-314F-40A6-8DE3-464587B8E1B2</gtr:id><gtr:title>MSA-C or SCA 17? A clinicopathological case update.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f07a33be90f6f19bd438059328a9dbb8"><gtr:id>f07a33be90f6f19bd438059328a9dbb8</gtr:id><gtr:otherNames>Doherty KM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>58c7eec4a906b1.58904398</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>65CCD75D-8FBE-41B1-8502-3A7581E93375</gtr:id><gtr:title>Clinicopathologic and molecular spectrum of-related mitochondrial disease.</gtr:title><gtr:parentPublicationTitle>Neurology. Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1d1503307a90897a52487453a039bddd"><gtr:id>1d1503307a90897a52487453a039bddd</gtr:id><gtr:otherNames>Bugiardini E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2376-7839</gtr:issn><gtr:outcomeId>5aa93ee9cf0145.41510653</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>383D098F-2EE8-4887-8A4B-C9A5C25F574C</gtr:id><gtr:title>Validation of next-generation sequencing technologies in genetic diagnosis of dementia.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/72f7fb44cb0e9d3dbae03fa9e859951a"><gtr:id>72f7fb44cb0e9d3dbae03fa9e859951a</gtr:id><gtr:otherNames>Beck J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>pm_15519_29_23998997</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7F6006E6-6F0B-48E7-9268-4D60FA90E8D6</gtr:id><gtr:title>Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a9ff70460a8a25a64715383958cc1a82"><gtr:id>a9ff70460a8a25a64715383958cc1a82</gtr:id><gtr:otherNames>Majounie E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>pm_15519_29_22406228</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4F1501E6-9B60-4957-BAE3-0EBBADFCC736</gtr:id><gtr:title>Phenotypic and molecular insights into spinal muscular atrophy due to mutations in BICD2.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8e200f814262dac4d6b88ac30584c047"><gtr:id>8e200f814262dac4d6b88ac30584c047</gtr:id><gtr:otherNames>Rossor AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>56a4096d9d8c15.84685086</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>068E5A4E-D98E-40B8-9857-07DE478C3782</gtr:id><gtr:title>Analysis of C9orf72 repeat expansions in a large series of clinically and pathologically diagnosed cases with atypical parkinsonism.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ff2cda0ff39441e9d379b03cb269851"><gtr:id>3ff2cda0ff39441e9d379b03cb269851</gtr:id><gtr:otherNames>Schottlaender LV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>546297449961a7.86208688</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2B7D5E63-D3DF-40C7-8325-728B97E3E26B</gtr:id><gtr:title>Exome sequencing reveals riboflavin transporter mutations as a cause of motor neuron disease.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/18049378950e97e3da96e50d647b5c6f"><gtr:id>18049378950e97e3da96e50d647b5c6f</gtr:id><gtr:otherNames>Johnson JO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>pm_15519_29_22740598</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A5041404-9AD2-423C-B34E-6C0275FF7F9A</gtr:id><gtr:title>Exome sequencing in an SCA14 family demonstrates its utility in diagnosing heterogeneous diseases.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fc13094f3092b2a2f90b97002cd8eb10"><gtr:id>fc13094f3092b2a2f90b97002cd8eb10</gtr:id><gtr:otherNames>Sailer A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>pm_15519_29_22675081</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9EC05327-13C5-4570-A931-D611FBD7CCDA</gtr:id><gtr:title>PKD or Not PKD: That is the question.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4aaa24babbcd19a7ca30f50b28b99d4e"><gtr:id>4aaa24babbcd19a7ca30f50b28b99d4e</gtr:id><gtr:otherNames>Balint B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>58c7eec8edab57.96583571</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FBB00FD8-B2E2-4CB2-951E-7BC90F5AFC2A</gtr:id><gtr:title>Next-generation sequencing in neuromuscular diseases.</gtr:title><gtr:parentPublicationTitle>Current opinion in neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/af3d01a303955ec87d9796b29ee01eb6"><gtr:id>af3d01a303955ec87d9796b29ee01eb6</gtr:id><gtr:otherNames>Efthymiou S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1350-7540</gtr:issn><gtr:outcomeId>58c7eec7f02423.19690192</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1CA8A0DE-B176-4D17-99EF-C44ECB581E68</gtr:id><gtr:title>Author response: A genome-wide association study in multiple system atrophy.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0a34ae6889d51d0636773dd2548e288e"><gtr:id>0a34ae6889d51d0636773dd2548e288e</gtr:id><gtr:otherNames>Scholz SW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>5aa93eeace4133.89132630</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EB8B5CDB-52B4-4FEF-A1CB-067A5F32D9F4</gtr:id><gtr:title>Multiple system atrophy is not caused by C9orf72 hexanucleotide repeat expansions.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0a34ae6889d51d0636773dd2548e288e"><gtr:id>0a34ae6889d51d0636773dd2548e288e</gtr:id><gtr:otherNames>Scholz SW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>546297442a8b88.32062614</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5B658CB6-C67F-4FD1-8FE9-71578122DAAF</gtr:id><gtr:title>Neuropathy target esterase impairments cause Oliver-McFarlane and Laurence-Moon syndromes.</gtr:title><gtr:parentPublicationTitle>Journal of medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4721812e6d535c3d1145e4ec8237e968"><gtr:id>4721812e6d535c3d1145e4ec8237e968</gtr:id><gtr:otherNames>Hufnagel RB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-2593</gtr:issn><gtr:outcomeId>56a4096e17bf55.05066889</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>64EEDCBD-2E11-4AAA-9C19-4CEB51B97DA4</gtr:id><gtr:title>Pathogenic VCP mutations induce mitochondrial uncoupling and reduced ATP levels.</gtr:title><gtr:parentPublicationTitle>Neuron</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fedc4404d626048147a389c1d14ecc32"><gtr:id>fedc4404d626048147a389c1d14ecc32</gtr:id><gtr:otherNames>Bartolome F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0896-6273</gtr:issn><gtr:outcomeId>pm_15519_29_23498975</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4F1FB302-F7D2-4D82-B79B-C9B8E79452EF</gtr:id><gtr:title>A novel HTRA1 exon 2 mutation causes loss of protease activity in a Pakistani CARASIL patient.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f3448b53cd01a1b60a66c2f94ca21c3"><gtr:id>9f3448b53cd01a1b60a66c2f94ca21c3</gtr:id><gtr:otherNames>Khaleeli Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>56a4096bdee9e2.31970876</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D2B5E05A-3E28-494F-89CE-82317B5D47E2</gtr:id><gtr:title>Clinical implications of genetic advances in Charcot-Marie-Tooth disease.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8e200f814262dac4d6b88ac30584c047"><gtr:id>8e200f814262dac4d6b88ac30584c047</gtr:id><gtr:otherNames>Rossor AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1759-4758</gtr:issn><gtr:outcomeId>pm_15519_29_24018473</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A4EBBB09-4EE1-4AE3-8A93-177BA9C67F20</gtr:id><gtr:title>The frequency of spinocerebellar ataxia type 23 in a UK population.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/41c4d0dfc03600335329f8ac761e66b0"><gtr:id>41c4d0dfc03600335329f8ac761e66b0</gtr:id><gtr:otherNames>Fawcett K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>pm_15519_29_23108490</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B610C0D3-3FA6-4581-8FB6-FBBA0DD17C32</gtr:id><gtr:title>Analysis of ATP13A2 in large neurodegeneration with brain iron accumulation (NBIA) and dystonia-parkinsonism cohorts.</gtr:title><gtr:parentPublicationTitle>Neuroscience letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1f031c0b2f78e03012bc542323de4d08"><gtr:id>1f031c0b2f78e03012bc542323de4d08</gtr:id><gtr:otherNames>Kruer MC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0304-3940</gtr:issn><gtr:outcomeId>pm_15519_29_22743658</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DDF0E602-8D5A-4DFB-BF84-105A0CCFC24F</gtr:id><gtr:title>Loss-of-Function Mutations in FRRS1L Lead to an Epileptic-Dyskinetic Encephalopathy.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7cbecc303d2e334d5905d7f14159341e"><gtr:id>7cbecc303d2e334d5905d7f14159341e</gtr:id><gtr:otherNames>Madeo M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>58c7eec54697a0.91691733</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E3D787F7-77CA-456B-8B87-2BCBAD9132F0</gtr:id><gtr:title>Pilot phenotype and natural history study of hereditary neuropathies caused by mutations in the HSPB1 gene.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8e200f814262dac4d6b88ac30584c047"><gtr:id>8e200f814262dac4d6b88ac30584c047</gtr:id><gtr:otherNames>Rossor AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>58c7eec65a8784.63257873</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2C38B92F-542C-4FD7-9CEE-2E1B3FF22B05</gtr:id><gtr:title>Rhabdomyolysis: a genetic perspective.</gtr:title><gtr:parentPublicationTitle>Orphanet journal of rare diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb7de9e0bdbda47bf81b86f2720f04e3"><gtr:id>bb7de9e0bdbda47bf81b86f2720f04e3</gtr:id><gtr:otherNames>Scalco RS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1750-1172</gtr:issn><gtr:outcomeId>56a4096c438747.55783436</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>18279822-E910-408C-B148-8158C9BF453D</gtr:id><gtr:title>Mutations in noncoding regions ofare a major cause of X-linked CMT.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/32eced6165160ce76ae4eaa88f46e3d0"><gtr:id>32eced6165160ce76ae4eaa88f46e3d0</gtr:id><gtr:otherNames>Tomaselli PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>58c7eec22d5770.85222790</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D77194D3-F7A9-4BBC-B8D8-DD6305AECDE5</gtr:id><gtr:title>The clinical and genetic heterogeneity of paroxysmal dyskinesias.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f9b6f09a6640fea0ca88338ba7ed5668"><gtr:id>f9b6f09a6640fea0ca88338ba7ed5668</gtr:id><gtr:otherNames>Gardiner AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>56a40966a7b457.83986332</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EAC0C0CD-4180-4C90-996B-36DB1E942479</gtr:id><gtr:title>Hypersomnia with dilated pupils in adenosine monophosphate deaminase (AMPD) deficiency.</gtr:title><gtr:parentPublicationTitle>Journal of sleep research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/454302726a4f2ef471ebd89121efa41c"><gtr:id>454302726a4f2ef471ebd89121efa41c</gtr:id><gtr:otherNames>Perumal MB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0962-1105</gtr:issn><gtr:outcomeId>pm_15519_29_24033727</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>96E20516-494C-45E8-8C35-C2741E0085BE</gtr:id><gtr:title>Forebrain deletion of the dystonia protein torsinA causes dystonic-like movements and loss of striatal cholinergic neurons.</gtr:title><gtr:parentPublicationTitle>eLife</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d07df80fc290c1d52c3bc40ece361da1"><gtr:id>d07df80fc290c1d52c3bc40ece361da1</gtr:id><gtr:otherNames>Pappas SS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2050-084X</gtr:issn><gtr:outcomeId>56a4096ba95413.70240517</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ED64DB9D-CFBF-4E75-8AAF-520400F463F6</gtr:id><gtr:title>SBF1 mutations associated with autosomal recessive axonal neuropathy with cranial nerve involvement.</gtr:title><gtr:parentPublicationTitle>Neurogenetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c9ffda67425e994f02c670de63593986"><gtr:id>c9ffda67425e994f02c670de63593986</gtr:id><gtr:otherNames>Manole A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1364-6745</gtr:issn><gtr:outcomeId>58c7eec3ea7c92.48760396</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A01129A3-7AA2-4876-B778-B5EC7FA445D6</gtr:id><gtr:title>Pathological ribonuclease H1 causes R-loop depletion and aberrant DNA segregation in mitochondria.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d0868462ff4eec27e8eea7f7c7c64375"><gtr:id>d0868462ff4eec27e8eea7f7c7c64375</gtr:id><gtr:otherNames>Akman G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>58c7eec89425b1.30939142</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>35E0B914-7E00-498A-8D89-76FD2EC19487</gtr:id><gtr:title>Multiple system atrophy: the application of genetics in understanding etiology.</gtr:title><gtr:parentPublicationTitle>Clinical autonomic research : official journal of the Clinical Autonomic Research Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5bb0da6bb7eb8d81a012bd35afacacdc"><gtr:id>5bb0da6bb7eb8d81a012bd35afacacdc</gtr:id><gtr:otherNames>Federoff M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0959-9851</gtr:issn><gtr:outcomeId>56a4096de2d5a4.27156370</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2B3A8BAB-1015-4AA3-974B-5A9A6AD3E443</gtr:id><gtr:title>Alpha-synuclein mRNA expression in oligodendrocytes in MSA.</gtr:title><gtr:parentPublicationTitle>Glia</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1a25a6988d5aadc65741d1b68af379f6"><gtr:id>1a25a6988d5aadc65741d1b68af379f6</gtr:id><gtr:otherNames>Asi YT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0894-1491</gtr:issn><gtr:outcomeId>54629741e1f2d4.25980501</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6984692B-9550-4F84-9113-0B4E879510B8</gtr:id><gtr:title>The Clinical Relevance of Microbleeds in Stroke study (CROMIS-2): rationale, design, and methods.</gtr:title><gtr:parentPublicationTitle>International journal of stroke : official journal of the International Stroke Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d6981c962662ff970fe9940bc30407e3"><gtr:id>d6981c962662ff970fe9940bc30407e3</gtr:id><gtr:otherNames>Charidimou A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1747-4930</gtr:issn><gtr:outcomeId>56a409684387d9.55215597</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F9A42521-1DD5-4E57-8F68-2C84679D204F</gtr:id><gtr:title>Analysis of the prion protein gene in multiple system atrophy.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/034f6f958aa47e49cbb180fb10e1d728"><gtr:id>034f6f958aa47e49cbb180fb10e1d728</gtr:id><gtr:otherNames>Chelban V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>58c7eec697bc97.94691774</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>70780950-2628-4B83-9808-966657C29194</gtr:id><gtr:title>Characteristics of Unruptured Compared to Ruptured Intracranial Aneurysms: A Multicenter Case-Control Study.</gtr:title><gtr:parentPublicationTitle>Neurosurgery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/91630dc25534e09c426f44e546f3e65c"><gtr:id>91630dc25534e09c426f44e546f3e65c</gtr:id><gtr:otherNames>Hostettler IC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0148-396X</gtr:issn><gtr:outcomeId>5aa93ee8329de4.53102184</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2317FCDE-408F-49BA-8011-DABA44E0719D</gtr:id><gtr:title>Hereditary leukoencephalopathy with axonal spheroids: a spectrum of phenotypes from CNS vasculitis to parkinsonism in an adult onset leukodystrophy series.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6867986db8e51578e846cfba3cd72c66"><gtr:id>6867986db8e51578e846cfba3cd72c66</gtr:id><gtr:otherNames>Lynch DS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>56a4096c135da9.29522020</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5D2CA080-09B0-48D7-A520-D811DE7B7DCA</gtr:id><gtr:title>Screening a UK amyotrophic lateral sclerosis cohort provides evidence of multiple origins of the C9orf72 expansion.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8d1a7eafc9d349e2e6367fcc16d31c49"><gtr:id>8d1a7eafc9d349e2e6367fcc16d31c49</gtr:id><gtr:otherNames>Fratta P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>54629743c60ff1.26431156</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D0589890-1716-40B0-8177-3A4B43937405</gtr:id><gtr:title>Sniffing out the cerebellum.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3544c3d604dfbcaee394d9a12def7ab8"><gtr:id>3544c3d604dfbcaee394d9a12def7ab8</gtr:id><gtr:otherNames>Houlden H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>pm_15519_29_22851611</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8972F2B0-D858-427D-965E-5439CF31129A</gtr:id><gtr:title>Defects in the CAPN1 Gene Result in Alterations in Cerebellar Development and Cerebellar Ataxia in Mice and Humans.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/52542eaf317f347220ec706e5b20b4a1"><gtr:id>52542eaf317f347220ec706e5b20b4a1</gtr:id><gtr:otherNames>Wang Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>58c7eec952ad95.18955916</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1ED0A60C-AC91-4C69-8D7A-ED073D0BD79E</gtr:id><gtr:title>PRUNE is crucial for normal brain development and mutated in microcephaly with neurodevelopmental impairment.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/008714e03cc79922a19d3b457141b891"><gtr:id>008714e03cc79922a19d3b457141b891</gtr:id><gtr:otherNames>Zollo M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>5aa93eea7a5a71.22024713</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7DC735FF-50F9-41D1-8951-EB077AA2F93C</gtr:id><gtr:title>Screening for mutations in the phosphatidylinositol 4-kinase 2-alpha gene in autosomal recessive hereditary spastic paraplegia.</gtr:title><gtr:parentPublicationTitle>Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cdebfc3106d26158fd0e21d9e4ce5d03"><gtr:id>cdebfc3106d26158fd0e21d9e4ce5d03</gtr:id><gtr:otherNames>Cleeter M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1471-180X</gtr:issn><gtr:outcomeId>Cnf12eK7rMm</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7FFD08FB-44F5-46B6-9651-5A4F93CC6AB8</gtr:id><gtr:title>THAP1 mutations in a Greek primary blepharospasm series.</gtr:title><gtr:parentPublicationTitle>Parkinsonism &amp; related disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7683c72a503be0311ba813667c505f75"><gtr:id>7683c72a503be0311ba813667c505f75</gtr:id><gtr:otherNames>Xiromerisiou G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1353-8020</gtr:issn><gtr:outcomeId>pm_15519_29_23036512</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2BD57139-152D-40F7-AF9F-561763035692</gtr:id><gtr:title>SIGMAR1 mutation associated with autosomal recessive Silver-like syndrome.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70045987ef050d49a7a1c26b398ecd06"><gtr:id>70045987ef050d49a7a1c26b398ecd06</gtr:id><gtr:otherNames>Horga A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>58c7eec78ed4f9.39489998</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5A6CE5EE-BF1F-46AC-86A5-8C472D88335B</gtr:id><gtr:title>Severe Dejerine-Sottas disease with respiratory failure and dysmorphic features in association with a PMP22 point mutation and a 3q23 microdeletion.</gtr:title><gtr:parentPublicationTitle>Journal of the peripheral nervous system : JPNS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ac050b4cbcf59e748973d74c7628ed4"><gtr:id>8ac050b4cbcf59e748973d74c7628ed4</gtr:id><gtr:otherNames>Voermans NC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1085-9489</gtr:issn><gtr:outcomeId>pm_15519_29_22734911</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CD31E33F-7F10-40F4-A306-9A70FCB12A3A</gtr:id><gtr:title>PRRT2 gene mutations: from paroxysmal dyskinesia to episodic ataxia and hemiplegic migraine.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f9b6f09a6640fea0ca88338ba7ed5668"><gtr:id>f9b6f09a6640fea0ca88338ba7ed5668</gtr:id><gtr:otherNames>Gardiner AR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>pm_15519_29_23077024</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F55A5594-949A-4714-BA36-1D4F53C0363C</gtr:id><gtr:title>Dopaminergic neuronal imaging in genetic Parkinson's disease: insights into pathogenesis.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fb527c8f47b11cfd2bb90849f52723e8"><gtr:id>fb527c8f47b11cfd2bb90849f52723e8</gtr:id><gtr:otherNames>McNeill A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_15519_29_23935950</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>574DB681-4D01-47C7-9B2B-5F483C8C6DF0</gtr:id><gtr:title>DYT6 Dystonia: A Neuropathological Study.</gtr:title><gtr:parentPublicationTitle>Neuro-degenerative diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b2ac56d4a5087705921cb2ad66bb2a3"><gtr:id>9b2ac56d4a5087705921cb2ad66bb2a3</gtr:id><gtr:otherNames>Paudel R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1660-2854</gtr:issn><gtr:outcomeId>56a40967256368.30094204</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D2734EB4-FD5C-4A39-AC6D-7FF87B8162DE</gtr:id><gtr:title>Exome sequencing uncovers hidden pathways in familial and sporadic ALS.</gtr:title><gtr:parentPublicationTitle>Nature neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9960cd808582e52821f0e586e2ba9176"><gtr:id>9960cd808582e52821f0e586e2ba9176</gtr:id><gtr:otherNames>Bettencourt C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1097-6256</gtr:issn><gtr:outcomeId>56a4096ca51bc1.18740967</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>025FB0FA-AF5C-4CD7-B4DD-579110326090</gtr:id><gtr:title>Glucocerebrosidase mutations confer a greater risk of dementia during Parkinson's disease course.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f9eabd2b081856a15607eca8c8bfce6c"><gtr:id>f9eabd2b081856a15607eca8c8bfce6c</gtr:id><gtr:otherNames>Set?-Salvia N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>pm_15519_29_22173904</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8CE1C0BE-920F-4137-BC5C-8D559622526F</gtr:id><gtr:title>DNA isolation protocol effects on nuclear DNA analysis by microarrays, droplet digital PCR, and whole genome sequencing, and on mitochondrial DNA copy number estimation.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/76c2f965aac424ae82975cc69a19e1f8"><gtr:id>76c2f965aac424ae82975cc69a19e1f8</gtr:id><gtr:otherNames>Nacheva E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5aa93ee8d92817.72281319</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AA15098C-FAAA-40EA-AC81-296438AC9643</gtr:id><gtr:title>The instability of the BTB-KELCH protein Gigaxonin causes Giant Axonal Neuropathy and constitutes a new penetrant and specific diagnostic test.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5da89de5ddb6f0c22aacb38b0bac15db"><gtr:id>5da89de5ddb6f0c22aacb38b0bac15db</gtr:id><gtr:otherNames>Boizot A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2051-5960</gtr:issn><gtr:outcomeId>5462974260e7f6.86064051</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>80321706-D260-402B-84CC-F926BA7B6A95</gtr:id><gtr:title>Severe axonal neuropathy is a late manifestation of SPG11.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c9ffda67425e994f02c670de63593986"><gtr:id>c9ffda67425e994f02c670de63593986</gtr:id><gtr:otherNames>Manole A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>58c7eec4819a78.36531428</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>41364572-B532-4A5D-B13A-DD02CC524BC1</gtr:id><gtr:title>Homozygous mutation incausing distal vacuolar myopathy and motor neuropathy.</gtr:title><gtr:parentPublicationTitle>Neurology. Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1d1503307a90897a52487453a039bddd"><gtr:id>1d1503307a90897a52487453a039bddd</gtr:id><gtr:otherNames>Bugiardini E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2376-7839</gtr:issn><gtr:outcomeId>5aa93ee895cc87.61684757</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E827E68E-C4EE-4A22-970D-B98758D7B529</gtr:id><gtr:title>Widespread Lewy body and tau accumulation in childhood and adult onset dystonia-parkinsonism cases with PLA2G6 mutations.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d8fab38dd5065abc5a928948b76aff2f"><gtr:id>d8fab38dd5065abc5a928948b76aff2f</gtr:id><gtr:otherNames>Pais?n-Ruiz C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>pm_15519_29_20619503</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D8A8B0F2-551A-4BEC-87D2-B145644D8631</gtr:id><gtr:title>Brain iron accumulation affects myelin-related molecular systems implicated in a rare neurogenetic disease family with neuropsychiatric features.</gtr:title><gtr:parentPublicationTitle>Molecular psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b7db88df9f44c9c37b5e7c23fe5b4135"><gtr:id>b7db88df9f44c9c37b5e7c23fe5b4135</gtr:id><gtr:otherNames>Heidari M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1359-4184</gtr:issn><gtr:outcomeId>56a409660ec789.93763757</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F28804AC-D722-4E30-AEDF-A0575FFA7DC3</gtr:id><gtr:title>Detection of novel mutations and review of published data suggests that hereditary spastic paraplegia caused by spastin (SPAST) mutations is found more often in males.</gtr:title><gtr:parentPublicationTitle>Journal of the neurological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ad6d814d95a541c7e3a165cbafd92058"><gtr:id>ad6d814d95a541c7e3a165cbafd92058</gtr:id><gtr:otherNames>Proukakis C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-510X</gtr:issn><gtr:outcomeId>CDnspG8uJ52</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E36A7876-E993-4669-B83E-BE5837E44DAD</gtr:id><gtr:title>Exome sequence reveals mutations in CoA synthase as a cause of neurodegeneration with brain iron accumulation.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0c476215aba277f7032e95532684d5dc"><gtr:id>0c476215aba277f7032e95532684d5dc</gtr:id><gtr:otherNames>Dusi S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>54629740d49f65.52906933</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>44726BA1-9733-41AF-8850-5C15DD64B395</gtr:id><gtr:title>A novel TUBB4A mutation suggests that genotype-phenotype correlation of H-ABC syndrome needs to be revisited.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fc98b863ea1e6ac2e57978c77cd38ad6"><gtr:id>fc98b863ea1e6ac2e57978c77cd38ad6</gtr:id><gtr:otherNames>Erro R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>56a4096a5893b9.24399116</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C837C3A5-246B-4DAC-BCB7-8E7568BA6CEE</gtr:id><gtr:title>Clinical variability and L-Dopa responsive Parkinsonism in hereditary spastic paraplegia 11.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5a2120c0ff4a9d24112d293975ce431d"><gtr:id>5a2120c0ff4a9d24112d293975ce431d</gtr:id><gtr:otherNames>Everett CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>pm_15519_29_22893306</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>85A4F0BF-021D-453E-BECB-6C781B9FF738</gtr:id><gtr:title>A 6.4 Mb duplication of the a-synuclein locus causing frontotemporal dementia and Parkinsonism: phenotype-genotype correlations.</gtr:title><gtr:parentPublicationTitle>JAMA neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/697536feebefd233256c0907479ff552"><gtr:id>697536feebefd233256c0907479ff552</gtr:id><gtr:otherNames>Kara E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2168-6149</gtr:issn><gtr:outcomeId>5462974332c0d5.57292373</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7F2CADDB-C0A1-42E0-BE01-86E7E05E5656</gtr:id><gtr:title>Novel HSAN1 mutation in serine palmitoyltransferase resides at a putative phosphorylation site that is involved in regulating substrate specificity.</gtr:title><gtr:parentPublicationTitle>Neuromolecular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4de2a860f153838d0613290971dc2033"><gtr:id>4de2a860f153838d0613290971dc2033</gtr:id><gtr:otherNames>Ernst D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1535-1084</gtr:issn><gtr:outcomeId>56a4096d69b521.57465978</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>07423DE6-BE8F-485E-9DE1-902BDD782CAF</gtr:id><gtr:title>Redefining the phenotype of ALSP andmutation-related leukodystrophy.</gtr:title><gtr:parentPublicationTitle>Neurology. Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/72581e71106155fae7679c5a668017b5"><gtr:id>72581e71106155fae7679c5a668017b5</gtr:id><gtr:otherNames>Lakshmanan R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2376-7839</gtr:issn><gtr:outcomeId>58c7eec299cae4.20362245</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>83AC739E-A913-49C7-94B0-648416D6B215</gtr:id><gtr:title>Thinning of the corpus callosum and cerebellar atrophy is correlated with phenotypic severity in a family with spastic paraplegia type 11.</gtr:title><gtr:parentPublicationTitle>Journal of clinical neurology (Seoul, Korea)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/14632e9fec0b4b9b740218552a278537"><gtr:id>14632e9fec0b4b9b740218552a278537</gtr:id><gtr:otherNames>Rajakulendran S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1738-6586</gtr:issn><gtr:outcomeId>ihqHziKzk1A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6CB1D694-342C-4C60-9E8E-51303152C0B5</gtr:id><gtr:title>a-Synucleinopathy associated with G51D SNCA mutation: a link between Parkinson's disease and multiple system atrophy?</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8cf5553107e55c233b68c1efaf1db243"><gtr:id>8cf5553107e55c233b68c1efaf1db243</gtr:id><gtr:otherNames>Kiely AP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn><gtr:outcomeId>pm_15519_29_23404372</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2AC99702-3C86-4B1B-A8F0-649C120C8F2E</gtr:id><gtr:title>Mutations in GBA2 cause autosomal-recessive cerebellar ataxia with spasticity.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/be4c0da55ab01c9f0e6393f9ed6fadce"><gtr:id>be4c0da55ab01c9f0e6393f9ed6fadce</gtr:id><gtr:otherNames>Hammer MB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>pm_15519_29_23332917</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4B63FDC6-6411-40C4-A2F8-5CE027E82DE8</gtr:id><gtr:title>What causes intracerebral bleeding after thrombolysis for acute ischaemic stroke? Recent insights into mechanisms and potential biomarkers.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4b03cc72ff363e8c8ae86303a127f41b"><gtr:id>4b03cc72ff363e8c8ae86303a127f41b</gtr:id><gtr:otherNames>Karaszewski B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>56a40968763867.14464972</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B47FF186-7834-41D5-AB54-A6C02600C1E9</gtr:id><gtr:title>Distinct clinical and neuropathological features of G51D SNCA mutation cases compared with SNCA duplication and H50Q mutation.</gtr:title><gtr:parentPublicationTitle>Molecular neurodegeneration</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8cf5553107e55c233b68c1efaf1db243"><gtr:id>8cf5553107e55c233b68c1efaf1db243</gtr:id><gtr:otherNames>Kiely AP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1750-1326</gtr:issn><gtr:outcomeId>56a4096a8a4488.71657139</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3E6F1695-3FE8-4079-B389-CAE56A3E484A</gtr:id><gtr:title>SPG11 Presenting with Tremor.</gtr:title><gtr:parentPublicationTitle>Tremor and other hyperkinetic movements (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/94931914f1fe9277fbe2bc12b6a4c8a0"><gtr:id>94931914f1fe9277fbe2bc12b6a4c8a0</gtr:id><gtr:otherNames>Schneider SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>2160-8288</gtr:issn><gtr:outcomeId>pm_15519_29_23439843</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5A6B249F-27D8-4CD0-B559-B2C9EFD5EC7E</gtr:id><gtr:title>Hereditary spastic paraplegia in Greece: characterisation of a previously unexplored population using next-generation sequencing.</gtr:title><gtr:parentPublicationTitle>European journal of human genetics : EJHG</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6867986db8e51578e846cfba3cd72c66"><gtr:id>6867986db8e51578e846cfba3cd72c66</gtr:id><gtr:otherNames>Lynch DS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1018-4813</gtr:issn><gtr:outcomeId>56a40968d83f88.32726274</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A519B029-979E-4480-8A66-1DEAF0514DAF</gtr:id><gtr:title>?-Propeller protein-associated neurodegeneration: a new X-linked dominant disorder with brain iron accumulation.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/15207479c0ab3461d4182e7e05fa69ea"><gtr:id>15207479c0ab3461d4182e7e05fa69ea</gtr:id><gtr:otherNames>Hayflick SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>pm_15519_29_23687123</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FBACE094-FF2A-40DF-88A2-796FBA728C84</gtr:id><gtr:title>Mutations in the gene PRRT2 cause paroxysmal kinesigenic dyskinesia with infantile convulsions.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c2ea971f41f8b71d54e54576d18e6ea4"><gtr:id>c2ea971f41f8b71d54e54576d18e6ea4</gtr:id><gtr:otherNames>Lee HY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>pm_15519_29_22543779</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D2E72C91-4EEE-43C8-A94E-87BE9C541398</gtr:id><gtr:title>Charcot-Marie-Tooth disease: frequency of genetic subtypes and guidelines for genetic testing.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6742175c859dc2842759f84e6dd6f0e6"><gtr:id>6742175c859dc2842759f84e6dd6f0e6</gtr:id><gtr:otherNames>Murphy SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>pm_15519_29_22577229</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>38749A6A-18C7-48B1-B887-44BA548DF351</gtr:id><gtr:title>C9orf72 expansions are the most common genetic cause of Huntington disease phenocopies.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/244cc363f830eda2f51ecf6bac87f6f0"><gtr:id>244cc363f830eda2f51ecf6bac87f6f0</gtr:id><gtr:otherNames>Hensman Moss DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>54629741286468.94539855</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0C607E03-66BA-4C12-94F4-5CE449123B06</gtr:id><gtr:title>Sporadic inclusion body myositis: the genetic contributions to the pathogenesis.</gtr:title><gtr:parentPublicationTitle>Orphanet journal of rare diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5740d7dfacf41317fd1190662cfe9c79"><gtr:id>5740d7dfacf41317fd1190662cfe9c79</gtr:id><gtr:otherNames>Gang Q</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1750-1172</gtr:issn><gtr:outcomeId>pm_540e192e192422e1e</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A7B84E25-F595-4310-B929-E749B61C3C94</gtr:id><gtr:title>The pallidopyramidal syndromes: nosology, aetiology and pathogenesis.</gtr:title><gtr:parentPublicationTitle>Current opinion in neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/697536feebefd233256c0907479ff552"><gtr:id>697536feebefd233256c0907479ff552</gtr:id><gtr:otherNames>Kara E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1350-7540</gtr:issn><gtr:outcomeId>pm_15519_29_23817214</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>59C54BB4-E087-470F-BB47-8A3B2B2FA947</gtr:id><gtr:title>Genetics of neurodegenerative diseases: an overview.</gtr:title><gtr:parentPublicationTitle>Handbook of clinical neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7e018d848f37709256b024c30ea7824c"><gtr:id>7e018d848f37709256b024c30ea7824c</gtr:id><gtr:otherNames>Pihlstr?m L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0072-9752</gtr:issn><gtr:outcomeId>5aa93eeb282eb9.28217907</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F63006E8-F43A-49FE-87F6-79ACC0F4717F</gtr:id><gtr:title>Creation of an open-access, mutation-defined fibroblast resource for neurological disease research.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/68ca09ebb1473b9780612d7b5d9dafef"><gtr:id>68ca09ebb1473b9780612d7b5d9dafef</gtr:id><gtr:otherNames>Wray S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_15519_29_22952635</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A6EA875E-A220-4F0C-B3E2-5668BAECB40A</gtr:id><gtr:title>Variable phenotypes are associated with PMP22 missense mutations.</gtr:title><gtr:parentPublicationTitle>Neuromuscular disorders : NMD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ccf0bc737932265eaa33cfdb00a4f429"><gtr:id>ccf0bc737932265eaa33cfdb00a4f429</gtr:id><gtr:otherNames>Russo M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0960-8966</gtr:issn><gtr:outcomeId>mGfeoxcFU9u</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B79731A5-C299-4666-AE26-5F6B7F3793FF</gtr:id><gtr:title>Insights from cerebellar transcriptomic analysis into the pathogenesis of ataxia.</gtr:title><gtr:parentPublicationTitle>JAMA neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9960cd808582e52821f0e586e2ba9176"><gtr:id>9960cd808582e52821f0e586e2ba9176</gtr:id><gtr:otherNames>Bettencourt C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2168-6149</gtr:issn><gtr:outcomeId>5462974283bc23.72125321</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C51166B2-D4F9-49CE-9945-CF39EBD977C4</gtr:id><gtr:title>Truncating and missense mutations in IGHMBP2 cause Charcot-Marie Tooth disease type 2.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bcb877e01dd9f33040f7fc09646ce4b6"><gtr:id>bcb877e01dd9f33040f7fc09646ce4b6</gtr:id><gtr:otherNames>Cottenie E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>56a4096f2b9fa4.77241995</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A6927ED9-D1B2-45DC-BB91-E54E6EFF5975</gtr:id><gtr:title>Novel mutations mapping to the fourth sodium channel domain of Nav1.7 result in variable clinical manifestations of primary erythromelalgia.</gtr:title><gtr:parentPublicationTitle>Neuromolecular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7276d1e256346a632b0a5edf660a0b74"><gtr:id>7276d1e256346a632b0a5edf660a0b74</gtr:id><gtr:otherNames>Cregg R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1535-1084</gtr:issn><gtr:outcomeId>pm_15519_29_23292638</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7690EA77-B1FA-497D-B843-1620CA72FEF3</gtr:id><gtr:title>TDP-43 pathology in a patient carrying G2019S LRRK2&amp;nbsp;mutation and a novel p.Q124E MAPT.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/79c943d719ca6749410f754081f54667"><gtr:id>79c943d719ca6749410f754081f54667</gtr:id><gtr:otherNames>Ling H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>pm_15519_29_23664753</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4908E818-798A-4A52-847C-27C2D9FE3090</gtr:id><gtr:title>Cryptic Amyloidogenic Elements in the 3' UTRs of Neurofilament Genes Trigger Axonal Neuropathy.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/86c42c663e0f22036e78de1c30a1c181"><gtr:id>86c42c663e0f22036e78de1c30a1c181</gtr:id><gtr:otherNames>Rebelo AP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>58c7eec5b50ae0.52037791</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9D9789AE-E28D-4747-A95C-A9E103550BF8</gtr:id><gtr:title>Triple trouble: a striking new phenotype or competing genes in a family with hereditary spastic paraplegia.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/034f6f958aa47e49cbb180fb10e1d728"><gtr:id>034f6f958aa47e49cbb180fb10e1d728</gtr:id><gtr:otherNames>Chelban V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>58c7eec9b92e09.73733099</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5FC44DC3-4113-49D5-BC80-67D52CF9E18A</gtr:id><gtr:title>Mutations in BICD2 cause dominant congenital spinal muscular atrophy and hereditary spastic paraplegia.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1707385a316c35c6294898aff4bc0ae7"><gtr:id>1707385a316c35c6294898aff4bc0ae7</gtr:id><gtr:otherNames>Oates EC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>pm_15519_29_23664120</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>818BF305-7026-43F1-9E3B-7AECB4C0F9FC</gtr:id><gtr:title>Cathepsin D deficiency causes juvenile-onset ataxia and distinctive muscle pathology.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/13a59fbd288093fca2ace1bf37b42241"><gtr:id>13a59fbd288093fca2ace1bf37b42241</gtr:id><gtr:otherNames>Hersheson J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>54629744764488.38556794</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3B103C83-2382-4F9C-885C-236DD454F9FD</gtr:id><gtr:title>Extended phenotypic spectrum of KIF5A mutations: From spastic paraplegia to axonal neuropathy.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/75880868018d92d0b7d54e2c82d1b2bc"><gtr:id>75880868018d92d0b7d54e2c82d1b2bc</gtr:id><gtr:otherNames>Liu YT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>5462974355cc11.45350617</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3241C12E-F3B2-445D-BC19-6FE0C61A9C65</gtr:id><gtr:title>Exome sequencing identifies a significant variant in methionyl-tRNA synthetase (MARS) in a family with late-onset CMT2.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/80583ad27ad24e91c0380658e597d61a"><gtr:id>80583ad27ad24e91c0380658e597d61a</gtr:id><gtr:otherNames>Gonzalez M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>pm_15519_29_23729695</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>830153FF-3235-4178-A480-22EDE62FC9BB</gtr:id><gtr:title>LRRK2 exonic variants and risk of multiple system atrophy.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4d05ae276ba007db1461e7f91f861892"><gtr:id>4d05ae276ba007db1461e7f91f861892</gtr:id><gtr:otherNames>Heckman MG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>54629744de35b6.66792199</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B7161101-659B-4096-A0F5-FD4379B7AB61</gtr:id><gtr:title>The effects of an intronic polymorphism in TOMM40 and APOE genotypes in sporadic inclusion body myositis.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5740d7dfacf41317fd1190662cfe9c79"><gtr:id>5740d7dfacf41317fd1190662cfe9c79</gtr:id><gtr:otherNames>Gang Q</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>5675dfa36250f</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2680B812-22D6-48A0-AFFD-7EE2C1FC571F</gtr:id><gtr:title>Genetic analysis of inherited leukodystrophies: genotype-phenotype correlations in the CSF1R gene.</gtr:title><gtr:parentPublicationTitle>JAMA neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/56b2d14505f1916bc463c5643c1c28d8"><gtr:id>56b2d14505f1916bc463c5643c1c28d8</gtr:id><gtr:otherNames>Guerreiro R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2168-6149</gtr:issn><gtr:outcomeId>pm_15519_29_23649896</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>961305C0-6B60-454B-AF24-6C9FB2C09B57</gtr:id><gtr:title>Mutations in the autoregulatory domain of ?-tubulin 4a cause hereditary dystonia.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/13a59fbd288093fca2ace1bf37b42241"><gtr:id>13a59fbd288093fca2ace1bf37b42241</gtr:id><gtr:otherNames>Hersheson J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn><gtr:outcomeId>pm_15519_29_23424103</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7926659B-1811-42BF-85FA-8AAF8339BED3</gtr:id><gtr:title>Clinical and genetic characterization of leukoencephalopathies in adults.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6867986db8e51578e846cfba3cd72c66"><gtr:id>6867986db8e51578e846cfba3cd72c66</gtr:id><gtr:otherNames>Lynch DS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>5aa93eea3185d2.01438087</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4B17085D-5B22-413D-9B03-BBE79FFAD14F</gtr:id><gtr:title>Genetic risk factors for intracranial aneurysms: a meta-analysis in more than 116,000 individuals.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8e8073c0bd0f69cf5756d64d9d62fcdc"><gtr:id>8e8073c0bd0f69cf5756d64d9d62fcdc</gtr:id><gtr:otherNames>Alg VS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>pm_15519_29_23733552</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6608DE13-C200-4146-82EC-FA183E3F4A3A</gtr:id><gtr:title>High frequency of the expanded C9ORF72 hexanucleotide repeat in familial and sporadic Greek ALS patients.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cc6be3b3e5ee776d6c6cd87eccb0be6f"><gtr:id>cc6be3b3e5ee776d6c6cd87eccb0be6f</gtr:id><gtr:otherNames>Mok KY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>pm_15519_29_22445326</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9685883D-CC56-48CB-B60A-82544277F5B1</gtr:id><gtr:title>A genome-wide association study in multiple system atrophy.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fc13094f3092b2a2f90b97002cd8eb10"><gtr:id>fc13094f3092b2a2f90b97002cd8eb10</gtr:id><gtr:otherNames>Sailer A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>58c7eec7bd0174.61165546</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DF177C72-0E10-483E-A060-76C3BE539DED</gtr:id><gtr:title>The inherited ataxias: genetic heterogeneity, mutation databases, and future directions in research and clinical diagnostics.</gtr:title><gtr:parentPublicationTitle>Human mutation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/13a59fbd288093fca2ace1bf37b42241"><gtr:id>13a59fbd288093fca2ace1bf37b42241</gtr:id><gtr:otherNames>Hersheson J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1059-7794</gtr:issn><gtr:outcomeId>pm_15519_29_22689585</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8470D5A4-31AB-47A0-BD3F-20F3F6750482</gtr:id><gtr:title>Developmental regulation of tau splicing is disrupted in stem cell-derived neurons from frontotemporal dementia patients with the 10 + 16 splice-site mutation in MAPT.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b39d653d4d3c3376c5d341f10c040edc"><gtr:id>b39d653d4d3c3376c5d341f10c040edc</gtr:id><gtr:otherNames>Sposito T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>56a40969555394.11783685</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FC85E3DE-B119-45FB-BD91-32E171708724</gtr:id><gtr:title>Charcot-Marie-Tooth disease type 2C and scapuloperoneal muscular atrophy overlap syndrome in a patient with the R232C TRPV4 mutation.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a0141d4dc212d3dc1de00d97ceee75f7"><gtr:id>a0141d4dc212d3dc1de00d97ceee75f7</gtr:id><gtr:otherNames>Koutsis G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>56a4096a280c82.49246620</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>42F6C20D-3F3F-42CA-94B2-6A87A16CFD32</gtr:id><gtr:title>Genetic linkage analysis of a large family with photoparoxysmal response.</gtr:title><gtr:parentPublicationTitle>Epilepsy research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e4bfae792d5ae9491325012d23555157"><gtr:id>e4bfae792d5ae9491325012d23555157</gtr:id><gtr:otherNames>Lo C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0920-1211</gtr:issn><gtr:outcomeId>rqxRz3qeX5X</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F30EF91A-B0A0-4910-879E-49EC47371C0A</gtr:id><gtr:title>The Parkinson's disease-linked proteins Fbxo7 and Parkin interact to mediate mitophagy.</gtr:title><gtr:parentPublicationTitle>Nature neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e905395803df499a5bf946eb9e5153e0"><gtr:id>e905395803df499a5bf946eb9e5153e0</gtr:id><gtr:otherNames>Burchell VS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1097-6256</gtr:issn><gtr:outcomeId>pm_15519_29_23933751</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>56A2AD3B-FC6B-42DE-AF56-523D34E0EDD2</gtr:id><gtr:title>Characterisation and validation of insertions and deletions in 173 patient exomes.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e624c5192e4cb8e4e04042cdb89976af"><gtr:id>e624c5192e4cb8e4e04042cdb89976af</gtr:id><gtr:otherNames>Lescai F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_15519_29_23251486</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D8CAE3CD-2375-4F5C-935E-EC4191275A85</gtr:id><gtr:title>a-Synuclein mutations cluster around a putative protein loop.</gtr:title><gtr:parentPublicationTitle>Neuroscience letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/697536feebefd233256c0907479ff552"><gtr:id>697536feebefd233256c0907479ff552</gtr:id><gtr:otherNames>Kara E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0304-3940</gtr:issn><gtr:outcomeId>pm_15519_29_23669636</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>43AE42D4-E372-4E90-83FB-7EB0A88B47D1</gtr:id><gtr:title>Genetic and clinical characteristics of-related Charcot-Marie-Tooth disease.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70045987ef050d49a7a1c26b398ecd06"><gtr:id>70045987ef050d49a7a1c26b398ecd06</gtr:id><gtr:otherNames>Horga A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>5aa93ee933f687.43989614</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1DA6EA04-6152-4D2A-92D3-19CE3224455D</gtr:id><gtr:title>KIF1A, an axonal transporter of synaptic vesicles, is mutated in hereditary sensory and autonomic neuropathy type 2.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5d631037f5320d11a281f3a0b1b2d319"><gtr:id>5d631037f5320d11a281f3a0b1b2d319</gtr:id><gtr:otherNames>Rivi?re JB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>qYoXnb2jbYh</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>27475798-4391-4CAB-A22E-FEADB218BB80</gtr:id><gtr:title>Pathological relationships involving iron and myelin may constitute a shared mechanism linking various rare and common brain diseases.</gtr:title><gtr:parentPublicationTitle>Rare diseases (Austin, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b7db88df9f44c9c37b5e7c23fe5b4135"><gtr:id>b7db88df9f44c9c37b5e7c23fe5b4135</gtr:id><gtr:otherNames>Heidari M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2167-5511</gtr:issn><gtr:outcomeId>58c7eec92aa0c7.66278096</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F7B68AD1-8D6B-4C79-AF28-85DF61850CF5</gtr:id><gtr:title>Mutations in the histone methyltransferase gene KMT2B cause complex early-onset dystonia.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0c984efdac34b58497e7b0f51d6d10eb"><gtr:id>0c984efdac34b58497e7b0f51d6d10eb</gtr:id><gtr:otherNames>Meyer E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>58c7eec300d1e8.51172808</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FBD0B883-1C0C-4DE9-8C3B-4FA4825454B7</gtr:id><gtr:title>Friedreich's ataxia and other hereditary ataxias in Greece: an 18-year perspective.</gtr:title><gtr:parentPublicationTitle>Journal of the neurological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a0141d4dc212d3dc1de00d97ceee75f7"><gtr:id>a0141d4dc212d3dc1de00d97ceee75f7</gtr:id><gtr:otherNames>Koutsis G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-510X</gtr:issn><gtr:outcomeId>54629740424d32.72626144</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BD83D8CF-DF98-4DDF-B914-91FCC24FFB1A</gtr:id><gtr:title>Absence of HINT1 mutations in a UK and Spanish cohort of patients with inherited neuropathies.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70045987ef050d49a7a1c26b398ecd06"><gtr:id>70045987ef050d49a7a1c26b398ecd06</gtr:id><gtr:otherNames>Horga A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn><gtr:outcomeId>56a4096997a557.19231071</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>56350119-E56A-47C3-9DBA-77E4894B407D</gtr:id><gtr:title>Mutations in SNX14 cause a distinctive autosomal-recessive cerebellar ataxia and intellectual disability syndrome.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a7dda45248e47eb0023a4ccbd6908c4e"><gtr:id>a7dda45248e47eb0023a4ccbd6908c4e</gtr:id><gtr:otherNames>Thomas AC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>56a4096eec8457.78218357</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>20971E8B-A9EF-4AE4-A6E0-62AA0BFEA6A8</gtr:id><gtr:title>MFN2 deletion of exons 7 and 8: founder mutation in the UK population.</gtr:title><gtr:parentPublicationTitle>Journal of the peripheral nervous system : JPNS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/230c6ae6cfa4b1a456b4b475e336d4da"><gtr:id>230c6ae6cfa4b1a456b4b475e336d4da</gtr:id><gtr:otherNames>Carr AS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1085-9489</gtr:issn><gtr:outcomeId>56a4096b7b6925.90339107</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C4D981AD-4F79-4ACA-90D2-CFDD54F2F3A1</gtr:id><gtr:title>The glucocerobrosidase E326K variant predisposes to Parkinson's disease, but does not cause Gaucher's disease.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f95aa813f473ac4f55c06f44414f70d4"><gtr:id>f95aa813f473ac4f55c06f44414f70d4</gtr:id><gtr:otherNames>Duran R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>pm_15519_29_23225227</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>116B3A42-8D39-45AD-8F41-F3DACB2C0AE8</gtr:id><gtr:title>Mutations in NKX6-2 Cause Progressive Spastic Ataxia and Hypomyelination.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/034f6f958aa47e49cbb180fb10e1d728"><gtr:id>034f6f958aa47e49cbb180fb10e1d728</gtr:id><gtr:otherNames>Chelban V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>5aa93ee97e6360.05809732</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C0ADB5F5-1F68-4D85-A4F2-E5B4E901E7D5</gtr:id><gtr:title>ADCY5 mutations are another cause of benign hereditary chorea.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ed0f28b35d5e4240d5af6d917b092bf"><gtr:id>8ed0f28b35d5e4240d5af6d917b092bf</gtr:id><gtr:otherNames>Mencacci NE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>56a4096ab9d4d9.60646755</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6867FFF3-0447-4849-8B6D-1F8BEF9CF615</gtr:id><gtr:title>Pantothenate kinase-associated neurodegeneration is not a synucleinopathy.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7c5c2253c4ba1d1ab5829aa152019a46"><gtr:id>7c5c2253c4ba1d1ab5829aa152019a46</gtr:id><gtr:otherNames>Li A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>pm_15519_29_22416811</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>710BA4E3-BDE5-49CA-935D-0D421261EE3B</gtr:id><gtr:title>Analysis of spinocerebellar ataxias due to expanded triplet repeats in Greek patients with cerebellar ataxia.</gtr:title><gtr:parentPublicationTitle>Journal of the neurological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a0141d4dc212d3dc1de00d97ceee75f7"><gtr:id>a0141d4dc212d3dc1de00d97ceee75f7</gtr:id><gtr:otherNames>Koutsis G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-510X</gtr:issn><gtr:outcomeId>pm_15519_29_22520093</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5170869B-E9D4-4466-ADD2-9FB2BA0C04E9</gtr:id><gtr:title>Tubular Aggregates and Cylindrical Spirals Have Distinct Immunohistochemical Signatures.</gtr:title><gtr:parentPublicationTitle>Journal of neuropathology and experimental neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8655b80f35da06543063892dc80fc48b"><gtr:id>8655b80f35da06543063892dc80fc48b</gtr:id><gtr:otherNames>Brady S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-3069</gtr:issn><gtr:outcomeId>58c7eec6e64d01.00619670</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5EA2549D-4824-4D39-A6D8-A7A5043A0973</gtr:id><gtr:title>Pure Cerebellar Ataxia with Homozygous Mutations in the PNPLA6 Gene.</gtr:title><gtr:parentPublicationTitle>Cerebellum (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f412cc6b7d29c6e9685797bea1d962d2"><gtr:id>f412cc6b7d29c6e9685797bea1d962d2</gtr:id><gtr:otherNames>Wiethoff S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1473-4222</gtr:issn><gtr:outcomeId>58c7eec3353206.91987181</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>05ECD2D8-6EBB-4AC1-9404-B16A30E605F6</gtr:id><gtr:title>Reply: The p.Ser107Leu in BICD2 is a mutation 'hot spot' causing distal spinal muscular atrophy.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8e200f814262dac4d6b88ac30584c047"><gtr:id>8e200f814262dac4d6b88ac30584c047</gtr:id><gtr:otherNames>Rossor AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>56a4096782a918.97249459</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F3B4B703-2E6D-42BE-8A99-625C874431B2</gtr:id><gtr:title>Diagnostic clues and manifesting carriers in fukutin-related protein (FKRP) limb-girdle muscular dystrophy.</gtr:title><gtr:parentPublicationTitle>Journal of the neurological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ff2cda0ff39441e9d379b03cb269851"><gtr:id>3ff2cda0ff39441e9d379b03cb269851</gtr:id><gtr:otherNames>Schottlaender LV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-510X</gtr:issn><gtr:outcomeId>56a4096e53c528.99196298</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>10322AEB-E86B-491B-A343-5F48F8F01C05</gtr:id><gtr:title>Recent advances in the genetics of cerebellar ataxias.</gtr:title><gtr:parentPublicationTitle>Current neurology and neuroscience reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fc13094f3092b2a2f90b97002cd8eb10"><gtr:id>fc13094f3092b2a2f90b97002cd8eb10</gtr:id><gtr:otherNames>Sailer A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1528-4042</gtr:issn><gtr:outcomeId>pm_15519_29_22527681</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AEBF87DF-176E-43DB-8247-93BFFF9ED521</gtr:id><gtr:title>Neuropathological features of genetically confirmed DYT1 dystonia: investigating disease-specific inclusions.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b2ac56d4a5087705921cb2ad66bb2a3"><gtr:id>9b2ac56d4a5087705921cb2ad66bb2a3</gtr:id><gtr:otherNames>Paudel R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2051-5960</gtr:issn><gtr:outcomeId>56a4096eb85313.64697040</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B1BAA119-248B-4990-8FEB-013C14C4AFDB</gtr:id><gtr:title>Assessment of Parkinson's disease risk loci in Greece.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/697536feebefd233256c0907479ff552"><gtr:id>697536feebefd233256c0907479ff552</gtr:id><gtr:otherNames>Kara E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>pm_15519_29_24080174</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>96950CD2-43F6-49DA-BBAD-E5C153F7951F</gtr:id><gtr:title>Kohlsch&amp;uuml;tter-T&amp;ouml;nz syndrome: mutations in ROGDI and evidence of genetic heterogeneity.</gtr:title><gtr:parentPublicationTitle>Human mutation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2e8088f2d6e90105cd78b127c6516c9f"><gtr:id>2e8088f2d6e90105cd78b127c6516c9f</gtr:id><gtr:otherNames>Tucci A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1059-7794</gtr:issn><gtr:outcomeId>pm_15519_29_23086778</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>09905635-37BA-4B6F-A3D2-1103B2014DC4</gtr:id><gtr:title>Mutational analysis of parkin and PINK1 in multiple system atrophy.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bd67cee39ecc846d62acf37d23c82716"><gtr:id>bd67cee39ecc846d62acf37d23c82716</gtr:id><gtr:otherNames>Brooks JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>pm_15519_29_20034704</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>14220597-420B-49DB-BFE6-4C20CC31D847</gtr:id><gtr:title>Somatic alpha-synuclein mutations in Parkinson's disease: hypothesis and preliminary data.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ad6d814d95a541c7e3a165cbafd92058"><gtr:id>ad6d814d95a541c7e3a165cbafd92058</gtr:id><gtr:otherNames>Proukakis C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>pm_15519_29_23674490</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E6727500-BB8D-44D2-8BE1-ACD49CC050B4</gtr:id><gtr:title>THAP1 mutations and dystonia phenotypes: genotype phenotype correlations.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7683c72a503be0311ba813667c505f75"><gtr:id>7683c72a503be0311ba813667c505f75</gtr:id><gtr:otherNames>Xiromerisiou G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>pm_15519_29_22903657</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>63E55124-25C4-4BB3-BC71-50D29AA89A22</gtr:id><gtr:title>Using human induced pluripotent stem cells to model cerebellar disease: hope and hype.</gtr:title><gtr:parentPublicationTitle>Journal of neurogenetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f412cc6b7d29c6e9685797bea1d962d2"><gtr:id>f412cc6b7d29c6e9685797bea1d962d2</gtr:id><gtr:otherNames>Wiethoff S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0167-7063</gtr:issn><gtr:outcomeId>56a4096b4492b0.58495591</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C46CDB0A-3954-4706-854D-D0B87C360A64</gtr:id><gtr:title>Recent advances in bulbar syndromes: genetic causes and disease mechanisms.</gtr:title><gtr:parentPublicationTitle>Current opinion in neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c9ffda67425e994f02c670de63593986"><gtr:id>c9ffda67425e994f02c670de63593986</gtr:id><gtr:otherNames>Manole A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1350-7540</gtr:issn><gtr:outcomeId>546297439f3932.11263958</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BAC9AA88-E813-4740-9F27-EB706D7CAA8B</gtr:id><gtr:title>DNA repair in the trinucleotide repeat disorders.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/59ac40b969c64db850e438e12bb3e323"><gtr:id>59ac40b969c64db850e438e12bb3e323</gtr:id><gtr:otherNames>Jones L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>58c7eec6304fc1.35669103</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AABA498C-F31C-488C-9291-348D4EA7ECA6</gtr:id><gtr:title>Genetic advances in sporadic inclusion body myositis.</gtr:title><gtr:parentPublicationTitle>Current opinion in rheumatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5740d7dfacf41317fd1190662cfe9c79"><gtr:id>5740d7dfacf41317fd1190662cfe9c79</gtr:id><gtr:otherNames>Gang Q</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1040-8711</gtr:issn><gtr:outcomeId>56a4096754e073.49998093</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>61EE10B8-23D1-4954-A21A-420AACCFA531</gtr:id><gtr:title>Defective N-linked protein glycosylation pathway in congenital myasthenic syndromes.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3544c3d604dfbcaee394d9a12def7ab8"><gtr:id>3544c3d604dfbcaee394d9a12def7ab8</gtr:id><gtr:otherNames>Houlden H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>pm_15519_29_23436500</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A3D59A87-CE5F-464D-921B-AAA5EE2085ED</gtr:id><gtr:title>Syndromic associations and RNF216 mutations.</gtr:title><gtr:parentPublicationTitle>Parkinsonism &amp; related disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6b7ff253acba98dc4017e32a051ce3e9"><gtr:id>6b7ff253acba98dc4017e32a051ce3e9</gtr:id><gtr:otherNames>Ganos C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1353-8020</gtr:issn><gtr:outcomeId>56a40966e735d9.20805480</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1DB7B0F2-D4E5-4296-90FE-0DE025499C75</gtr:id><gtr:title>The MAPT p.A152T variant is a risk factor associated with tauopathies with atypical clinical and neuropathological features.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/697536feebefd233256c0907479ff552"><gtr:id>697536feebefd233256c0907479ff552</gtr:id><gtr:otherNames>Kara E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>pm_15519_29_22595371</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G1001253</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>